Purchase Warrant. THIS CERTIFIES THAT, in consideration of funds duly paid by or on behalf of [INVESTOR] (“Holder”), as registered owner of this Purchase Warrant, to American BriVision (Holding) Corporation., a Nevada company (the “Company”), Holder is entitled, at any time or from time to time from [●], 2020 (the “Commencement Date”), and at or before 5:00 p.m., Eastern time, [●], 2023, (the “Expiration Date”), but not thereafter, to subscribe for, purchase and receive, in whole or in part, up to [●] shares of of common stock of the Company, par value $0.001 (the “Shares”), subject to adjustment as provided in Section 5 hereof. If the Expiration Date is a day on which banking institutions are authorized by law to close, then this Purchase Warrant may be exercised on the next succeeding day which is not such a day in accordance with the terms herein. During the period ending on the Expiration Date, the Company agrees not to take any action that would terminate this Purchase Warrant. This Purchase Warrant is initially exercisable at $5.00 per Share; provided, however, that upon the occurrence of any of the events specified in Section 4 hereof, the rights granted by this Purchase Warrant, including the exercise price per Share and the number of Shares to be received upon such exercise, shall be adjusted as therein specified. The term “Exercise Price” shall mean the initial exercise price or the adjusted exercise price, depending on the context. Capitalized terms used and not otherwise defined herein shall have the meanings set forth in that certain Exchange Agreement, dated April 5, 2020, between the Company and the Holder (the “Agreement”)
Appears in 2 contracts
Sources: Purchase Warrant (American BriVision (Holding) Corp), Purchase Warrant (American BriVision (Holding) Corp)
Purchase Warrant. THIS CERTIFIES THAT, in consideration of funds duly paid by or on behalf of [INVESTOR] ▇.▇. ▇▇▇▇▇▇▇▇ & Co., Inc. (“Holder” or “▇▇▇▇▇▇▇▇”), as registered owner of this Purchase Warrant, to American BriVision (Holding) Corporation.Collab Z Inc., a Nevada company corporation (the “Company”), Holder is entitled, at any time or from time to time from beginning [●], 2020 2026 (the “Commencement Date”), and at or before 5:00 p.m., Eastern time, [●], 2023, 20301 (the “Expiration Date”), but not thereafter, to subscribe for, purchase and receive, in whole or in part, up to [●] shares of of common stock of the Company, par value $0.001 per share (the “Shares”), subject to adjustment as provided in Section 5 6 hereof. If the Expiration Date is a day on which banking institutions are authorized by law to close, then this Purchase Warrant may be exercised on the next succeeding day which is not such a day in accordance with the terms herein. During the period ending on the Expiration Date, the Company agrees not to take any action that would terminate this Purchase Warrant. This Purchase Warrant is initially exercisable at $5.00 [●] per ShareShare2; provided, however, that upon the occurrence of any of the events specified in Section 4 6 hereof, the rights granted by this Purchase Warrant, including the exercise price per Share and the number of Shares to be received upon such exercise, shall be adjusted as therein specified. The term “Exercise Price” shall mean the initial exercise price or the adjusted exercise price, depending on the context. Capitalized terms used and Notwithstanding anything to the contrary herein, this Purchase Warrant will not otherwise defined herein shall have be exercisable or convertible more than five years from the meanings set forth in that certain Exchange Agreement, dated April 5, 2020, between commencement of sales under the Company and Company’s public offering pursuant to the Holder Company’s Registration Statement on Form S-1 (the “Agreement”No. 333-[•]).
Appears in 2 contracts
Sources: Underwriting Agreement (Collab Z Inc.), Purchase Warrant Agreement (Collab Z Inc.)
Purchase Warrant. THIS CERTIFIES THAT, in consideration of funds duly paid by or on behalf of [INVESTOR] Kingswood Capital Markets, division of Benchmark Investments, LLC (“Holder”), as registered owner of this Purchase Warrant, to American BriVision (Holding) Corporation.Splash Beverage Group, Inc., a Nevada company Colorado corporation (the “Company”), Holder is entitled, at any time or from time to time from [●]December 10, 2020 2021 (the “Commencement Date”), and at or before 5:00 p.m., Eastern time, [●]June 10, 2023, 2026 (the “”Expiration Date”), but not thereafter, to subscribe for, purchase and receive, in whole or in part, up to [●__] shares of of common stock of the Company, no par value $0.001 per share (the “Shares”), subject to adjustment as provided in Section 5 6 hereof. If the Expiration Date is a day on which banking institutions are authorized by law to close, then this Purchase Warrant may be exercised on the next succeeding day which is not such a day in accordance with the terms herein. During the period ending on the Expiration Date, the Company agrees not to take any action that would terminate this Purchase Warrant. This Purchase Warrant is initially exercisable at $5.00 4.60 per Share; provided, however, that upon the occurrence of any of the events specified in Section 4 6 hereof, the rights granted by this Purchase Warrant, including the exercise price per Share and the number of Shares to be received upon such exercise, shall be adjusted as therein specified. The term “Exercise Price” shall mean the initial exercise price or the adjusted exercise price, depending on the context. Capitalized terms used and not otherwise defined herein The term “Effective Date” shall have mean June 10, 2021, the meanings set forth in that certain Exchange Agreement, dated April 5, 2020, between date on which the Registration Statement on Form S-1 (File No. 333-255091) of the Company was declared effective by the Securities and the Holder (the “Agreement”)Exchange Commission.
Appears in 2 contracts
Sources: Underwriting Agreement (Splash Beverage Group, Inc.), Representative’s Warrant Agreement (Splash Beverage Group, Inc.)
Purchase Warrant. THIS CERTIFIES THAT, in consideration of funds duly paid by or on behalf of [INVESTOR●] (“Holder”), as registered owner of this Purchase Warrant, to American BriVision (Holding) Corporation.Hartford Creative Group, a Nevada company corporation (the “Company”), Holder is entitled, at any time or from time to time from beginning [●], 2020 2025 (the “Commencement Date”), and at or before 5:00 p.m., Eastern time, [●], 2023, 202_1 (the “Expiration Date”), but not thereafter, to subscribe for, purchase and receive, in whole or in part, up to [●] shares of of common stock of the Company, par value $0.001 per share (the “Shares”), subject to adjustment as provided in Section 5 6 hereof. If the Expiration Date is a day on which banking institutions are authorized by law to close, then this Purchase Warrant may be exercised on the next succeeding day which is not such a day in accordance with the terms herein. During the period ending on the Expiration Date, the Company agrees not to take any action that would terminate this Purchase Warrant. This Purchase Warrant is initially exercisable at $5.00 [●] per ShareShare2; provided, however, that upon the occurrence of any of the events specified in Section 4 6 hereof, the rights granted by this Purchase Warrant, including the exercise price per Share and the number of Shares to be received upon such exercise, shall be adjusted as therein specified. The term “Exercise Price” shall mean the initial exercise price or the adjusted exercise price, depending on the context. Capitalized terms used and Notwithstanding anything to the contrary herein, this Purchase Warrant will not otherwise defined herein shall have be exercisable or convertible more than five years from the meanings set forth in that certain Exchange Agreement, dated April 5, 2020, between commencement of sales under the Company and Company’s public offering pursuant to the Holder Company’s Registration Statement on Form S-1 (the “Agreement”No. 333-285158).
Appears in 2 contracts
Sources: Underwriting Agreement (Hartford Creative Group, Inc.), Underwriting Agreement (Hartford Creative Group, Inc.)
Purchase Warrant. THIS CERTIFIES THAT, in consideration of funds duly paid by or on behalf of [INVESTOR] Boustead Securities, LLC (“Holder”), as registered owner of this Purchase Warrant, to American BriVision (Holding) Corporation.Hempacco Co., Inc., a Nevada company corporation (the “Company”), Holder is entitled, at any time or from time to time from beginning [●], 2020 202_ (the “Commencement Date”), and at or before 5:00 p.m., Eastern time, [●], 2023, 202_1 (the “Expiration Date”), but not thereafter, to subscribe for, purchase and receive, in whole or in part, up to [●] shares of of common stock of the Company, par value $0.001 per share (the “Shares”), subject to adjustment as provided in Section 5 6 hereof. If the Expiration Date is a day on which banking institutions are authorized by law to close, then this Purchase Warrant may be exercised on the next succeeding day which is not such a day in accordance with the terms herein. During the period ending on the Expiration Date, the Company agrees not to take any action that would terminate this Purchase Warrant. This Purchase Warrant is initially exercisable at $5.00 [●] per ShareShare2; provided, however, that upon the occurrence of any of the events specified in Section 4 6 hereof, the rights granted by this Purchase Warrant, including the exercise price per Share and the number of Shares to be received upon such exercise, shall be adjusted as therein specified. The term “Exercise Price” shall mean the initial exercise price or the adjusted exercise price, depending on the context. Capitalized terms used and not otherwise defined herein shall have the meanings set forth in that certain Exchange Agreement, dated April 5, 2020, between the Company and the Holder (the “Agreement”).
Appears in 2 contracts
Sources: Underwriting Agreement (Hempacco Co., Inc.), Underwriting Agreement (Hempacco Co., Inc.)
Purchase Warrant. THIS CERTIFIES THAT, in consideration of funds duly paid by or on behalf of [INVESTOR] Kingswood Capital Markets, division of Benchmark Investments, Inc. (“Holder”), as registered owner of this Purchase Warrant, to American BriVision (Holding) Corporation.ComSovereign Holding Corp., a Nevada company corporation (the “Company”), Holder is entitled, at any time or from time to time from [●]July 21, 2020 2021 (the “Commencement Date”), and at or before 5:00 p.m., Eastern time, [●]January 21, 2023, 2026 (the “”Expiration Date”), but not thereafter, to subscribe for, purchase and receive, in whole or in part, up to [●] 154,216 shares of of common stock of the Company, par value $0.001 0.0001 per share (the “Shares”), subject to adjustment as provided in Section 5 6 hereof. If the Expiration Date is a day on which banking institutions are authorized by law to close, then this Purchase Warrant may be exercised on the next succeeding day which is not such a day in accordance with the terms herein. During the period ending on the Expiration Date, the Company agrees not to take any action that would terminate this Purchase Warrant. This Purchase Warrant is initially exercisable at $5.00 5.1875 per Share; provided, however, that upon the occurrence of any of the events specified in Section 4 6 hereof, the rights granted by this Purchase Warrant, including the exercise price per Share and the number of Shares to be received upon such exercise, shall be adjusted as therein specified. The term “Exercise Price” shall mean the initial exercise price or the adjusted exercise price, depending on the context. Capitalized terms used and not otherwise defined herein The term “Effective Date” shall have mean January 21, 2021, the meanings set forth in that certain Exchange Agreement, dated April 5, 2020, between date on which the Registration Statement on Form S-1 (File No. 333-248490) of the Company was declared effective by the Securities and the Holder (the “Agreement”)Exchange Commission.
Appears in 2 contracts
Sources: Purchase Warrant Agreement (ComSovereign Holding Corp.), Underwriting Agreement (ComSovereign Holding Corp.)
Purchase Warrant. THIS CERTIFIES THAT, in consideration of funds duly paid by or on behalf of [INVESTOR] The Benchmark Company, LLC (“Holder”), as registered owner of this Purchase Warrant, to American BriVision (Holding) Corporation.SU Group Holdings Limited, a Nevada an exempted company with limited liability incorporated under the laws of the Cayman Islands (the “Company”), Holder is entitled, at any time or from time to time from [●]beginning July 23, 2020 2024 (the “Commencement Date”), and ending at or before 5:00 p.m., Eastern time, [●]January 23, 20232029, which will be the fifth anniversary of the commencement of sales pursuant to the Company’s Registration Statement on Form F-1 (File No. 333-275705) (such date, the “Expiration Date”), but not thereafter, to subscribe for, purchase and receive, in whole or in part, up to [●] shares of of common stock 62,500 (the “Shares”) of the Company’s ordinary shares, par value $0.001 HK$0.01 per share (the “Ordinary Shares”), subject to adjustment as provided in Section 5 6 hereof. If the Expiration Date is a day on which banking institutions are authorized by law to close, then this Purchase Warrant may be exercised on the next succeeding day which is not such a day in accordance with the terms herein. During the period ending on the Expiration Date, the Company agrees not to take any action that would terminate this Purchase Warrant. This Purchase Warrant is initially exercisable at $5.00 4.00 per Share; provided, however, that upon the occurrence of any of the events specified in Section 4 6 hereof, the rights granted by this Purchase Warrant, including the exercise price per Share and the number of Shares to be received upon such exercise, shall be adjusted as therein specified. The adjustment to the exercise price will be made either according to the specified criteria or to the nominal value of the Share at the time of issuance, whichever is higher. The term “Exercise Price” shall mean the initial exercise price or the adjusted exercise price, depending on the context. Capitalized terms used and not otherwise defined herein shall have the meanings set forth in that certain Exchange Agreement, dated April 5, 2020, between the Company and the Holder (the “Agreement”).
Appears in 2 contracts
Sources: Underwriting Agreement (SU Group Holdings LTD), Purchase Warrant Agreement (SU Group Holdings LTD)
Purchase Warrant. THIS CERTIFIES THAT, in consideration of funds duly paid by or on behalf of [INVESTOR] R▇▇▇ Capital Partners, LLC (“Holder”), as registered owner of this Purchase Warrant, to American BriVision (Holding) Corporation.The Joint Corp., a Nevada company Delaware corporation (the “Company”), Holder is entitled, at any time or from time to time from [●]November 10, 2020 2015 (the “Commencement Date”), and until at or before 5:00 p.m., Eastern time, [●]November 10, 2023, 2018 (the “Expiration Date”), but not thereafter, to subscribe for, purchase and receive, in whole or in part, up to [●] 22,500 shares of of common stock of the Company, par value $0.001 per share (the “Shares”), subject to adjustment as provided in Section 5 6 hereof. If the Expiration Date is a day on which banking institutions are authorized by law to close, then this Purchase Warrant may be exercised on the next succeeding day which is not such a day in accordance with the terms herein. During the period commencing on the Effective Date and ending on the Expiration Date, the Company agrees not to take any action that would terminate this Purchase Warrant. This Purchase Warrant is initially exercisable at $5.00 8.125 per Share; provided, however, that upon the occurrence of any of the events specified in Section 4 6 hereof, the rights granted by this Purchase Warrant, including the exercise price per Share and the number of Shares to be received upon such exercise, shall be adjusted as therein specified. The term “Exercise Price” shall mean the initial exercise price or the adjusted exercise price, depending on the context. Capitalized terms used and not otherwise defined herein The term “Effective Date” shall have mean November 10, 2014, the meanings set forth in that certain Exchange Agreement, dated April 5, 2020, between date on which the Registration Statement on Form S-1 (File No. 333-198860) of the Company was declared effective by the Securities and the Holder (the “Agreement”)Exchange Commission.
Appears in 1 contract
Sources: Purchase Warrant (JOINT Corp)
Purchase Warrant. THIS CERTIFIES THAT, in consideration of funds duly paid by or on behalf of [INVESTOR] D▇▇▇▇▇ ▇▇▇▇▇ SECURITIES, INC. (“Holder”), as registered owner of this Purchase Warrant, to American BriVision (Holding) Corporation.Sigma Labs, Inc., a Nevada company corporation (the “Company”), Holder is entitled, at any time or from time to time from [●]November 7, 2020 2019 (the “Commencement Date”), and at or before 5:00 p.m., Eastern time, [●]November 7, 2023, 2024 (the “Expiration Date”), but not thereafter, to subscribe for, purchase and receive, in whole or in part, up to [●] ________________ shares of of common stock of the Company, par value $0.001 per share (the “Shares”), subject to adjustment as provided in Section 5 6 hereof. If the Expiration Date is a day on which banking institutions are authorized by law to close, then this Purchase Warrant may be exercised on the next succeeding day which is not such a day in accordance with the terms herein. During the period ending on the Expiration Date, the Company agrees not to take any action that would terminate this Purchase Warrant. This Purchase Warrant is initially exercisable at $5.00 ________________ per Share; provided, however, that upon the occurrence of any of the events specified in Section 4 6 hereof, the rights granted by this Purchase Warrant, including the exercise price per Share and the number of Shares to be received upon such exercise, shall be adjusted as therein specified. The term “Exercise Price” shall mean the initial exercise price or the adjusted exercise price, depending on the context. Capitalized terms used and not otherwise defined herein shall have the meanings set forth in that certain Exchange Agreement, dated April 5, 2020, between the Company and the Holder (the “Agreement”).
Appears in 1 contract
Purchase Warrant. THIS CERTIFIES THAT, in consideration of funds duly paid by or on behalf of [INVESTOR] ▇▇ ▇▇▇▇▇▇, division of Benchmark Investments, LLC (“Holder”), as registered owner of this Purchase WarrantWarrant issued by Guardforce AI Co., to American BriVision (Holding) Corporation.Limited, a Nevada Cayman Islands company (the “Company”), Holder is entitled, at any time or from time to time from [●]March 29, 2020 2022 (the “Commencement Date”), and until at or before 5:00 p.m., Eastern time, [●]September 28, 2023, 2026 (the “Expiration Date”), but not thereafter, to subscribe for, purchase and receive, in whole or in part, up to [●] shares of of common stock 180,723 Ordinary Shares of the Company, par value $0.001 0.003 per share (the “Ordinary Shares”), subject to adjustment as provided in Section 5 6 hereof. If the Expiration Date is a day on which banking institutions are authorized by law to close, then this Purchase Warrant may be exercised on the next succeeding day which is not such a day in accordance with the terms herein. During the period ending on the Expiration Date, the Company agrees not to take any action that would terminate this Purchase Warrant. This Purchase Warrant is initially exercisable at $5.00 5.1875 per Share; provided, however, that upon the occurrence of any of the events specified in Section 4 6 hereof, the rights granted by this Purchase Warrant, including the exercise price per Share and the number of Ordinary Shares to be received upon such exercise, shall be adjusted as therein specified. The term “Exercise Price” shall mean the initial exercise price or the adjusted exercise price, depending on the context. Capitalized terms used and not otherwise defined herein The term “Effective Date” shall have mean September 28, 2021, the meanings set forth in that certain Exchange Agreement, dated April 5, 2020, between date on which the Registration Statement on Form F-1 (File No. 333-258054) of the Company was declared effective by the Securities and the Holder (the “Agreement”)Exchange Commission.
Appears in 1 contract
Purchase Warrant. THIS CERTIFIES THAT, in consideration of funds duly paid by for value received, [•] or on behalf of [INVESTOR] its assigns (“Holder”), as registered owner of this Purchase Warrant, to American BriVision (Holding) Corporation., a Nevada company (the “Company”), Holder is entitled, at any time or from time to time from [●•], 2020 2016 (the “Commencement Date”), and until at or before 5:00 p.m., Eastern time, [●•], 2023, 2020 (the “Expiration Date”), but not thereafter, to subscribe for, purchase and receive, in whole or in part, up to [●•] shares of of common stock of Naked Brand Group, Inc., a Nevada corporation (the “Company”), par value $0.001 per share (the “Shares”), subject to adjustment as provided in Section 5 hereof. If the Expiration Date is a day on which banking institutions are authorized by law to close, then this Purchase Warrant may be exercised on the next succeeding day which is not such a day in accordance with the terms herein. During the period ending on the Expiration Date, the Company agrees not to take any action that would terminate this Purchase Warrant. This Purchase Warrant is initially exercisable at $5.00 [•] per Share; provided, however, that upon the occurrence of any of the events specified in Section 4 5 hereof, the rights granted by this Purchase Warrant, including the exercise price per Share and the number of Shares to be received upon such exercise, shall be adjusted as therein specified. The term “Exercise Price” shall mean the initial exercise price or the adjusted exercise price, depending on the context. Capitalized terms used and not otherwise defined herein The term “Effective Date” shall have mean [•], 2015, the meanings set forth in that certain Exchange Agreement, dated April 5, 2020, between date on which the Registration Statement on Form S-1 (File No. 333-207110) of the Company and the Holder (the “AgreementRegistration Statement”) was declared effective by the U.S. Securities and Exchange Commission (the “Commission”).
Appears in 1 contract
Sources: Purchase Warrant Agreement (Naked Brand Group Inc.)
Purchase Warrant. THIS CERTIFIES THAT, in consideration of funds duly paid by or on behalf of [INVESTOR] _______ (“Holder”), as registered owner of this Purchase Warrant, to American BriVision (Holding) Corporation.Sigma Labs, Inc., a Nevada company corporation (the “Company”), Holder is entitled, at any time or from time to time from [●]September 29, 2020 (the “Commencement Date”), and at or before 5:00 p.m., Eastern time, [●]April 2, 2023, 2025 (the “Expiration Date”), but not thereafter, to subscribe for, purchase and receive, in whole or in part, up to [●] _______ shares of of common stock of the Company, par value $0.001 per share (the “Shares”), subject to adjustment as provided in Section 5 6 hereof. If the Expiration Date is a day on which banking institutions are authorized by law to close, then this Purchase Warrant may be exercised on the next succeeding day which is not such a day in accordance with the terms herein. During the period ending on the Expiration Date, the Company agrees not to take any action that would terminate this Purchase Warrant. This Purchase Warrant is initially exercisable at $5.00 3.64 per Share; provided, however, that upon the occurrence of any of the events specified in Section 4 6 hereof, the rights granted by this Purchase Warrant, including the exercise price per Share and the number of Shares to be received upon such exercise, shall be adjusted as therein specified. The term “Exercise Price” shall mean the initial exercise price or the adjusted exercise price, depending on the context. Capitalized terms used and not otherwise defined herein shall have the meanings set forth in that certain Exchange Agreement, dated April 5, 2020, between the Company and the Holder (the “Agreement”).
Appears in 1 contract
Purchase Warrant. THIS CERTIFIES THAT, in consideration of funds duly paid by or on behalf of [INVESTOR●] (“Holder”), as registered owner of this Purchase Warrant, to American BriVision (Holding) Cardiff Lexington Corporation., a Nevada company corporation (the “Company”), Holder is entitled, at any time or from time to time from beginning [●], 2020 202_ (the “Commencement Date”), and at or before 5:00 p.m., Eastern time, [●], 2023, 202_1 (the “Expiration Date”), but not thereafter, to subscribe for, purchase and receive, in whole or in part, up to [●] shares of of common stock of the Company, par value $0.001 per share (the “Shares”), subject to adjustment as provided in Section 5 6 hereof. If the Expiration Date is a day on which banking institutions are authorized by law to close, then this Purchase Warrant may be exercised on the next succeeding day which is not such a day in accordance with the terms herein. During the period ending on the Expiration Date, the Company agrees not to take any action that would terminate this Purchase Warrant. This Purchase Warrant is initially exercisable at $5.00 [●] per ShareShare2; provided, however, that upon the occurrence of any of the events specified in Section 4 6 hereof, the rights granted by this Purchase Warrant, including the exercise price per Share and the number of Shares to be received upon such exercise, shall be adjusted as therein specified. The term “Exercise Price” shall mean the initial exercise price or the adjusted exercise price, depending on the context. Capitalized terms used and Notwithstanding anything to the contrary herein, this Purchase Warrant will not otherwise defined herein shall have be exercisable or convertible more than five years from the meanings set forth in that certain Exchange Agreement, dated April 5, 2020, between commencement of sales under the Company and Company’s public offering pursuant to the Holder Company’s Registration Statement on Form S-1 (the “Agreement”No. 333-273324).
Appears in 1 contract
Purchase Warrant. THIS CERTIFIES THAT, in consideration of funds duly paid by or on behalf of [INVESTOR] E▇ ▇▇▇▇▇▇, division of Benchmark Investments, LLC (“Holder”), as registered owner of this Purchase Warrant, to American BriVision (Holding) Corporation.Treasure Global Inc, a Nevada company Delaware corporation (the “Company”), Holder is entitled, at any time or from time to time from [●]February 10, 2020 2023 (the “Commencement Date”), and at or before 5:00 p.m., Eastern time, [●]August 10, 2023, 2027 (the “Expiration Date”), but not thereafter, to subscribe for, purchase and receive, in whole or in part, up to [●____] shares of of common stock of the Company, par value $0.001 0.00001 per share (the “Shares”), subject to adjustment as provided in Section 5 6 hereof. If the Expiration Date is a day on which banking institutions are authorized by law to close, then this Purchase Warrant may be exercised on the next succeeding day which is not such a day in accordance with the terms herein. During the period ending on the Expiration Date, the Company agrees not to take any action that would terminate this Purchase Warrant. This Purchase Warrant is initially exercisable at $5.00 per Share; provided, however, that upon the occurrence of any of the events specified in Section 4 6 hereof, the rights granted by this Purchase Warrant, including the exercise price per Share and the number of Shares to be received upon such exercise, shall be adjusted as therein specified. The term “Exercise Price” shall mean the initial exercise price or the adjusted exercise price, depending on the context. Capitalized terms used and not otherwise defined herein The term “Effective Date” shall have mean August 10, 2022, the meanings set forth in that certain Exchange Agreement, dated April 5, 2020, between date on which the Registration Statement on Form S-1 (File No. 333-264364) of the Company was declared effective by the Securities and the Holder (the “Agreement”)Exchange Commission.
Appears in 1 contract
Purchase Warrant. THIS CERTIFIES THAT, in consideration of funds duly paid by or on behalf of [INVESTOR] YA II PN, LTD. (“Holder” or “YA II”), as registered owner of this Purchase Warrant, to American BriVision (Holding) Corporation.Micronet Enertec Technologies, Inc., a Nevada company Delaware corporation (the “Company”), Holder is entitled, at any time or from time to time from [●]June 30, 2020 2016 (the “Commencement Date”), and at or before 5:00 p.m., Eastern time, [●]June 30, 2023, 2021 (the “”Expiration Date”), but not thereafter, to subscribe for, purchase and receive, in whole or in part, up to [●] 66,000 shares of of common stock of the Company, par value $0.001 per share (the “Shares”), subject to adjustment as provided in Section 5 6 hereof. If the Expiration Date is a day on which banking institutions are authorized by law to close, then this Purchase Warrant may be exercised on the next succeeding day which is not such a day in accordance with the terms herein. During the period ending on the Expiration Date, the Company agrees not to take any action that would terminate this the Purchase Warrant. This Purchase Warrant is initially exercisable at $5.00 4.30 per Share; provided, however, that upon the occurrence of any of the events specified in Section 4 6 hereof, the rights granted by this Purchase Warrant, including the exercise price per Share and the number of Shares to be received upon such exercise, shall be adjusted as therein specified. The term “Exercise Price” shall mean the initial exercise price or the adjusted exercise price, depending on the context. Capitalized terms used and not otherwise defined herein shall have the meanings set forth in that certain Exchange Agreement, dated April 5, 2020, between the Company and the Holder (the “Agreement”).
Appears in 1 contract
Sources: Purchase Warrant (Micronet Enertec Technologies, Inc.)
Purchase Warrant. THIS CERTIFIES THAT, in consideration of funds duly paid by or on behalf of [INVESTOR] Aegis Capital Corp. (“Holder”), as registered owner of this Purchase Warrant, to American BriVision (Holding) Corporation.AspenBio Pharma, Inc., a Nevada company Colorado corporation (the “Company”), Holder is entitled, at any time or from time to time from [●]June 19, 2020 2013 (the “Commencement Date”), and at or before 5:00 p.m., Eastern time, [●]June 19, 2023, 2017 (the “”Expiration Date”), but not thereafter, to subscribe for, purchase and receive, in whole or in part, up to [●] 305,000 shares of of common stock of the Company, no par value $0.001 per share (the “Shares”), subject to adjustment as provided in Section 5 6 hereof. If the Expiration Date is a day on which banking institutions are authorized by law to close, then this Purchase Warrant may be exercised on the next succeeding day which is not such a day in accordance with the terms herein. During the period ending on the Expiration Date, the Company agrees not to take any action that would terminate this the Purchase Warrant. This Purchase Warrant is initially exercisable at $5.00 2.50 per Share; provided, however, that upon the occurrence of any of the events specified in Section 4 6 hereof, the rights granted by this Purchase Warrant, including the exercise price per Share and the number of Shares to be received upon such exercise, shall be adjusted as therein specified. The term “Exercise Price” shall mean the initial exercise price or the adjusted exercise price, depending on the context. Capitalized terms used and not otherwise defined herein shall have the meanings set forth in that certain Exchange Agreement, dated April 5, 2020, between the Company and the Holder (the “Agreement”).
Appears in 1 contract
Purchase Warrant. THIS CERTIFIES THAT, in consideration of funds $100 duly paid by or on behalf of [INVESTOR] I-Bankers Securities, Inc. (“"Holder”"), as registered owner of this Purchase Warrant, to American BriVision (Holding) Corporation.SGOCO Group, a Nevada company Ltd. (the “"Company”"), Holder is entitled, at any time or from time to time from [●]June 12, 2020 2012 (the “"Commencement Date”"), and at or before 5:00 p.m., Eastern timeTime, [●]until December 20, 2023, 2015 (the “"Expiration Date”"), but not thereafter, to subscribe for, purchase and receive, in whole or in part, up to [●] 66,667 shares of of common ordinary stock of the Company, par value $0.001 .001 per share (the “"Shares”), ") subject to adjustment as provided in Section 5 hereof. If the Expiration Date is a day on which banking institutions are authorized by law to close, then this Purchase Warrant may be exercised on the next succeeding day which is not such a day in accordance with the terms herein. During the period ending on the Expiration Date, the Company agrees not to take any action that would terminate this the Purchase Warrant. This Purchase Warrant is initially exercisable at $5.00 6.00 per ShareShare (120%) of the price of the Shares sold in the Offering) so purchased; provided, however, that upon the occurrence of any of the events specified in Section 4 5 hereof, the rights granted by this Purchase Warrant, including the exercise price per Share and the number of Shares to be received upon such exercise, shall be adjusted as therein specified. The term “"Exercise Price” " shall mean the initial exercise price or the adjusted exercise price, depending on the context. Capitalized terms used This Purchase Warrants and not otherwise defined herein shall all of the Shares have the meanings set forth in that certain Exchange Agreement, dated April 5, 2020, between been registered by the Company with the Securities and the Holder Exchange Commission pursuant to Form F-1 (the “Agreement”Registration No. 333-170674), effective on December 20, 2010.
Appears in 1 contract
Purchase Warrant. THIS CERTIFIES THAT, in consideration of funds duly paid by or on behalf of [INVESTOR] P.▇. ▇▇▇▇▇ (“Holder”), as registered owner of this Purchase Warrant, to American BriVision (Holding) Corporation.Edison Nation, Inc., a Nevada company corporation (the “Company”), Holder is entitled, at any time or from time to time from [●], 2020 the date hereof (the “Commencement Date”), and at or before 5:00 p.m., Eastern time, [●]December 31, 2023, 2020 (the “Expiration Date”), but not thereafter, to subscribe for, purchase and receive, in whole or in part, up to [●] 50,000 shares of of common stock of the Company, par value $0.001 per share (the “Shares”), subject to adjustment as provided in Section 5 hereof. If the Expiration Date is a day on which banking institutions are authorized by law to close, then this Purchase Warrant may be exercised on the next succeeding day which is not such a day in accordance with the terms herein. During the period ending on the Expiration Date, the Company agrees not to take any action that would terminate this Purchase Warrant. This Purchase Warrant is initially exercisable at a fixed amount of $5.00 2.00 per Share; provided, however, that upon the occurrence of any of the events specified in Section 4 5 hereof, the rights granted by this Purchase Warrant, including the exercise price per Share and the number of Shares to be received upon such exercise, shall be adjusted as therein specified. The term “Exercise Price” shall mean the initial exercise price or the adjusted exercise price, depending on the context. Capitalized terms used and not otherwise defined herein shall have the meanings set forth in that certain Exchange Agreement, dated April 5, 2020, between the Company and the Holder (the “Agreement”).
Appears in 1 contract
Purchase Warrant. THIS CERTIFIES THAT, in consideration of funds duly paid by or on behalf of [INVESTOR] Kingswood Capital Markets, division of Benchmark Investments, Inc. (“Holder”), as registered owner of this Purchase Warrant, to American BriVision (Holding) Corporation.ComSovereign Holding Corp., a Nevada company corporation (the “Company”), Holder is entitled, at any time or from time to time from [●]August 10, 2020 2021 (the “Commencement Date”), and at or before 5:00 p.m., Eastern time, [●]February 10, 2023, 2026 (the “”Expiration Date”), but not thereafter, to subscribe for, purchase and receive, in whole or in part, up to [●] 198,776 shares of of common stock of the Company, par value $0.001 0.0001 per share (the “Shares”), subject to adjustment as provided in Section 5 6 hereof. If the Expiration Date is a day on which banking institutions are authorized by law to close, then this Purchase Warrant may be exercised on the next succeeding day which is not such a day in accordance with the terms herein. During the period ending on the Expiration Date, the Company agrees not to take any action that would terminate this Purchase Warrant. This Purchase Warrant is initially exercisable at $5.00 5.3125 per Share; provided, however, that upon the occurrence of any of the events specified in Section 4 6 hereof, the rights granted by this Purchase Warrant, including the exercise price per Share and the number of Shares to be received upon such exercise, shall be adjusted as therein specified. The term “Exercise Price” shall mean the initial exercise price or the adjusted exercise price, depending on the context. Capitalized terms used and not otherwise defined herein The term “Effective Date” shall have mean February 10, 2021, the meanings set forth in that certain Exchange Agreement, dated April 5, 2020, between date on which the Registration Statement on Form S-1 (File No. 333-252780) of the Company was declared effective by the Securities and Exchange Commission. This Purchase Warrant is one of a series of Purchase Warrants to purchase an aggregate of 225,882 shares issued by the Holder Company on February 12, 2021 (collectively, the “AgreementPurchase Warrants”).
Appears in 1 contract
Sources: Purchase Warrant Agreement (ComSovereign Holding Corp.)
Purchase Warrant. THIS CERTIFIES THAT, in consideration of funds duly paid by or on behalf of [INVESTOR] The Benchmark Company, LLC (“Holder”), as registered owner of this Purchase Warrant, to American BriVision (Holding) Corporation.Fly-E Group, Inc., a Nevada company corporation incorporated under the law of the State of Delaware (the “Company”), Holder is entitled, at any time or from time to time from [●]December 7, 2020 2024 (the “Commencement Date”), and at or before 5:00 p.m., Eastern New York City time, [●]June 7, 2023, 2029 (the “Expiration Date”), but not thereafter, to subscribe for, purchase and receive, in whole or in part, up to [●] 112,500 shares of of common stock of the Company, par value $0.001 0.01 per share (the “Shares”), subject to adjustment as provided in Section 5 6 hereof. If the Expiration Date is a day on which banking institutions in the State of New York are authorized by law to close, then this Purchase Warrant may be exercised on the next succeeding day which is not such a day in accordance with the terms herein. During the period ending on the Expiration Date, the Company agrees not to take any action that would terminate this Purchase Warrant. This Purchase Warrant is initially exercisable at $5.00 4.00 per Share; provided, however, that upon the occurrence of any of the events specified in Section 4 6 hereof, the rights granted by this Purchase Warrant, including the exercise price per Share and the number of Shares to be received upon such exercise, shall be adjusted as therein specified. The term “Exercise Price” shall mean the initial exercise price or the adjusted exercise price, depending on the context. Capitalized terms used and not otherwise defined herein The term “Effective Date” shall have mean May 14, 2024, the meanings set forth in that certain Exchange Agreement, dated April 5, 2020, between date on which the Registration Statement on Form S-1 (File No. 333-276830) of the Company was declared effective by the Securities and the Holder Exchange Commission (the “AgreementCommission”).
Appears in 1 contract
Sources: Representative’s Warrant Agreement (Fly-E Group, Inc.)
Purchase Warrant. THIS CERTIFIES THAT, in consideration of funds duly paid by or on behalf of [INVESTOR] Kingswood Capital Markets, division of Benchmark Investments, Inc. (“Holder”), as registered owner of this Purchase Warrant, to American BriVision (Holding) Corporation.ComSovereign Holding Corp., a Nevada company corporation (the “Company”), Holder is entitled, at any time or from time to time from [●]August 10, 2020 2021 (the “Commencement Date”), and at or before 5:00 p.m., Eastern time, [●]February 10, 2023, 2026 (the “”Expiration Date”), but not thereafter, to subscribe for, purchase and receive, in whole or in part, up to [●____] shares of of common stock of the Company, par value $0.001 0.0001 per share (the “Shares”), subject to adjustment as provided in Section 5 6 hereof. If the Expiration Date is a day on which banking institutions are authorized by law to close, then this Purchase Warrant may be exercised on the next succeeding day which is not such a day in accordance with the terms herein. During the period ending on the Expiration Date, the Company agrees not to take any action that would terminate this Purchase Warrant. This Purchase Warrant is initially exercisable at $5.00 5.3125 per Share; provided, however, that upon the occurrence of any of the events specified in Section 4 6 hereof, the rights granted by this Purchase Warrant, including the exercise price per Share and the number of Shares to be received upon such exercise, shall be adjusted as therein specified. The term “Exercise Price” shall mean the initial exercise price or the adjusted exercise price, depending on the context. Capitalized terms used and not otherwise defined herein The term “Effective Date” shall have mean February 10, 2021, the meanings set forth in that certain Exchange Agreement, dated April 5, 2020, between date on which the Registration Statement on Form S-1 (File No. 333-252780) of the Company was declared effective by the Securities and the Holder (the “Agreement”)Exchange Commission.
Appears in 1 contract
Sources: Underwriting Agreement (ComSovereign Holding Corp.)
Purchase Warrant. THIS CERTIFIES THAT, in consideration of funds duly paid by or on behalf of [INVESTOR●] (“Holder”), as registered owner of this Purchase Warrant, to American BriVision (Holding) Corporation.Gameverse Interactive Corp, a Nevada company corporation (the “Company”), Holder is entitled, at any time or from time to time from beginning [●], 2020 2025 (the “Commencement Date”), and at or before 5:00 p.m., Eastern time, [●], 2023, 20301 (the “Expiration Date”), but not thereafter, to subscribe for, purchase and receive, in whole or in part, up to [●] shares of of common stock of the Company, par value $0.001 per share (the “Shares”), subject to adjustment as provided in Section 5 6 hereof. If the Expiration Date is a day on which banking institutions are authorized by law to close, then this Purchase Warrant may be exercised on the next succeeding day which is not such a day in accordance with the terms herein. During the period ending on the Expiration Date, the Company agrees not to take any action that would terminate this Purchase Warrant. This Purchase Warrant is initially exercisable at $5.00 [●] per ShareShare2; provided, however, that upon the occurrence of any of the events specified in Section 4 6 hereof, the rights granted by this Purchase Warrant, including the exercise price per Share and the number of Shares to be received upon such exercise, shall be adjusted as therein specified. The term “Exercise Price” shall mean the initial exercise price or the adjusted exercise price, depending on the context. Capitalized terms used and Notwithstanding anything to the contrary herein, this Purchase Warrant will not otherwise defined herein shall have be exercisable or convertible more than five years from the meanings set forth in that certain Exchange Agreement, dated April 5, 2020, between commencement of sales under the Company and Company’s public offering pursuant to the Holder Company’s Registration Statement on Form S-1 (the “Agreement”No. 333-286068).
Appears in 1 contract
Sources: Underwriting Agreement (Gameverse Interactive Corp)
Purchase Warrant. THIS CERTIFIES THAT, in consideration of funds duly paid by or on behalf of [INVESTOR] J▇▇▇ ▇▇ (“Holder”), as registered owner of this Purchase Warrant, to American BriVision (Holding) Corporation.Senmiao Technology Limited, a Nevada company corporation (the “Company”), Holder is entitled, at any time or from time to time from [●]August 8, 2020 2021 (the “Commencement Date”), and at or before 5:00 p.m., Eastern time, [●]February 8, 2023, 2026 (the “”Expiration Date”), but not thereafter, to subscribe for, purchase and receive, in whole or in part, up to [●] 380,435 shares of of common stock of the Company, par value $0.001 per share (the “Shares”), subject to adjustment as provided in Section 5 6 hereof. If the Expiration Date is a day on which banking institutions are authorized by law to close, then this Purchase Warrant may be exercised on the next succeeding day which is not such a day in accordance with the terms herein. During the period ending on the Expiration Date, the Company agrees not to take any action that would terminate this Purchase Warrant. This Purchase Warrant is initially exercisable at $5.00 1.38 per Share; provided, however, that upon the occurrence of any of the events specified in Section 4 6 hereof, the rights granted by this Purchase Warrant, including the exercise price per Share and the number of Shares to be received upon such exercise, shall be adjusted as therein specified. The term “Exercise Price” shall mean the initial exercise price or the adjusted exercise price, depending on the context. Capitalized terms used and not otherwise defined herein shall have the meanings set forth in that certain Exchange Agreement, dated April 5, 2020, between the Company and the Holder (the “Agreement”).
Appears in 1 contract
Sources: Purchase Warrant Agreement (Senmiao Technology LTD)
Purchase Warrant. THIS CERTIFIES THAT, in consideration of funds duly paid by or on behalf of [INVESTOR] Kingswood Capital Markets, division of Benchmark Investments, Inc. (“Holder”), as registered owner of this Purchase Warrant, to American BriVision (Holding) Corporation.ComSovereign Holding Corp., a Nevada company corporation (the “Company”), Holder is entitled, at any time or from time to time from [●]August 10, 2020 2021 (the “Commencement Date”), and at or before 5:00 p.m., Eastern time, [●]February 10, 2023, 2026 (the “”Expiration Date”), but not thereafter, to subscribe for, purchase and receive, in whole or in part, up to [●] 27,106 shares of of common stock of the Company, par value $0.001 0.0001 per share (the “Shares”), subject to adjustment as provided in Section 5 6 hereof. If the Expiration Date is a day on which banking institutions are authorized by law to close, then this Purchase Warrant may be exercised on the next succeeding day which is not such a day in accordance with the terms herein. During the period ending on the Expiration Date, the Company agrees not to take any action that would terminate this Purchase Warrant. This Purchase Warrant is initially exercisable at $5.00 5.3125 per Share; provided, however, that upon the occurrence of any of the events specified in Section 4 6 hereof, the rights granted by this Purchase Warrant, including the exercise price per Share and the number of Shares to be received upon such exercise, shall be adjusted as therein specified. The term “Exercise Price” shall mean the initial exercise price or the adjusted exercise price, depending on the context. Capitalized terms used and not otherwise defined herein The term “Effective Date” shall have mean February 10, 2021, the meanings set forth in that certain Exchange Agreement, dated April 5, 2020, between date on which the Registration Statement on Form S-1 (File No. 333-252780) of the Company was declared effective by the Securities and Exchange Commission. This Purchase Warrant is one of a series of Purchase Warrants to purchase an aggregate of 225,882 shares issued by the Holder Company on February 12, 2021 (collectively, the “AgreementPurchase Warrants”).
Appears in 1 contract
Sources: Purchase Warrant Agreement (ComSovereign Holding Corp.)
Purchase Warrant. THIS CERTIFIES THAT, in consideration of funds duly paid by or on behalf of [INVESTOR] ▇▇▇▇▇▇▇▇▇ ▇▇▇▇▇▇▇▇▇▇ (“Holder”), as registered owner of this Purchase Warrant, to American BriVision (Holding) Corporation.Odyssey Group International, Inc., a Nevada company corporation (the “Company”), Holder is entitled, at any time or from time to time from [●]August 6, 2020 (the “Commencement Effective Date”), and at or before 5:00 p.m., Eastern time, [●]August 6, 2023, 2024 (the “Expiration Date”), but not thereafter, to subscribe for, purchase and receive, in whole or in part, up to [●] 220,000 shares of (the “Shares”) of common stock of the Company, par value $0.001 per share (the “SharesCommon Stock”), subject to adjustment as provided in Section 5 6 hereof. The total Shares issuable pursuant to all Purchase Warrants is referred to herein as the “Warrant Shares.” If the Expiration Date is a day on which banking institutions are authorized by law to close, then this Purchase Warrant may be exercised on the next succeeding day which is not such a day in accordance with the terms herein. During the period ending on the Expiration Date, the Company agrees not to take any action that would terminate this Purchase Warrant. This Purchase Warrant is initially exercisable at $5.00 0.01 per Share; provided, however, that upon the occurrence of any of the events specified in Section 4 6 hereof, the rights granted by this Purchase Warrant, including the exercise price per Share and the number of Shares to be received upon such exercise, shall be adjusted as therein specified. The term “Exercise Price” shall mean the initial exercise price or the adjusted exercise price, depending on the context. Capitalized terms used and not otherwise defined herein shall have the meanings set forth in that certain Exchange Agreement, dated April 5, 2020, between the Company and the Holder (the “Agreement”).
Appears in 1 contract
Sources: Purchase Warrant (Odyssey Group International, Inc.)
Purchase Warrant. THIS CERTIFIES THAT, in consideration of funds duly paid by or on behalf of [INVESTOR] D▇▇▇▇▇ ▇▇▇▇▇ SECURITIES, INC. (“Holder”), as registered owner of this Purchase Warrant, to American BriVision (Holding) Corporation.Sigma Labs, Inc., a Nevada company corporation (the “Company”), Holder is entitled, at any time or from time to time from [●]October 6, 2020 2018 (the “Commencement Date”), and at or before 5:00 p.m., Eastern time, [●]October 6, 2023, 2023 (the “Expiration Date”), but not thereafter, to subscribe for, purchase and receive, in whole or in part, up to [●] ________________ shares of of common stock of the Company, par value $0.001 per share (the “Shares”), subject to adjustment as provided in Section 5 6 hereof. If the Expiration Date is a day on which banking institutions are authorized by law to close, then this Purchase Warrant may be exercised on the next succeeding day which is not such a day in accordance with the terms herein. During the period ending on the Expiration Date, the Company agrees not to take any action that would terminate this Purchase Warrant. This Purchase Warrant is initially exercisable at $5.00 ________________ per Share; provided, however, that upon the occurrence of any of the events specified in Section 4 6 hereof, the rights granted by this Purchase Warrant, including the exercise price per Share and the number of Shares to be received upon such exercise, shall be adjusted as therein specified. The term “Exercise Price” shall mean the initial exercise price or the adjusted exercise price, depending on the context. Capitalized terms used and not otherwise defined herein shall have the meanings set forth in that certain Exchange Agreement, dated April 5, 2020, between the Company and the Holder (the “Agreement”).
Appears in 1 contract
Purchase Warrant. THIS CERTIFIES THAT, in consideration of funds duly paid by or on behalf of [INVESTOR] Kingswood Capital Partners, L.P. (“Holder”), as registered owner of this Purchase Warrant, to American BriVision (Holding) Corporation.Rebel Holdings, Inc., a Nevada company corporation (the “Company”), Holder is entitled, at any time or from time to time from [●]August 4, 2020 2022 (the “Commencement Date”), and at or before 5:00 p.m., Eastern time, [●]February 4, 2023, 2027 (the “Expiration Date”), but not thereafter, to subscribe for, purchase and receive, in whole or in part, up to [●] _____ shares of of common stock of the Company, par value $0.001 per share (the “Shares”), subject to adjustment as provided in Section 5 6 hereof. If the Expiration Date is a day on which banking institutions are authorized by law to close, then this Purchase Warrant may be exercised on the next succeeding day which is not such a day in accordance with the terms herein. During the period ending on the Expiration Date, the Company agrees not to take any action that would terminate this Purchase Warrant. This Purchase Warrant is initially exercisable at $5.00 ______ per Share; provided, however, that upon the occurrence of any of the events specified in Section 4 6 hereof, the rights granted by this Purchase Warrant, including the exercise price per Share and the number of Shares to be received upon such exercise, shall be adjusted as therein specified. The term “Exercise Price” shall mean the initial exercise price or the adjusted exercise price, depending on the context. Capitalized terms used and not otherwise defined herein The term “Effective Date” shall have mean February 4, 2022, the meanings set forth in that certain Exchange Agreement, dated April 5, 2020, between date on which the Registration Statement on Form S-1 (File No. 333-260646) of the Company was declared effective by the Securities and the Holder (the “Agreement”)Exchange Commission.
Appears in 1 contract
Purchase Warrant. THIS CERTIFIES THAT, in consideration of funds duly paid by or on behalf of [INVESTOR] Kingswood Capital Markets, division of Benchmark Investments, Inc., or its designees (the “Holder”), as registered owner of this purchase warrant (“Purchase Warrant”), to American BriVision (Holding) Corporation.Grove, Inc., a Nevada company corporation (the “Company”), Holder is entitled, at any time or from time to time from [●], 2020 the date hereof (the “Commencement Initial Exercise Date”), and at or before 5:00 p.m., Eastern time, [●], 2023, 3 (the “Expiration Date”), but not thereafterthereafter and subject to redemption, at the sole discretion of the Company, pursuant to Section 6 herein, to subscribe for, purchase and receive, in whole or in part, up to [●] shares of of common stock of the Companystock, par value $0.001 per share (the “SharesCommon Stock”), of the Company, subject to adjustment as provided in Section 5 hereof7 hereof (the “Shares”). If the Expiration Date is a day on which banking institutions are authorized by law to close, then this Purchase Warrant may be exercised on the next succeeding day day, which is not such a day in accordance with the terms herein. During the period ending on the Expiration Date, the Company agrees not to take any action that would terminate this Purchase Warrant. This Purchase Warrant is initially exercisable at $5.00 $ [●]4 per Share; provided, however, that upon the occurrence of any of the events specified in Section 4 7 hereof, the rights granted by this Purchase Warrant, including the exercise price per Share and the number of Shares to be received upon such exercise, shall be adjusted as therein specified. The term “Exercise Price” shall mean the initial exercise price or the adjusted exercise price, depending on the context. Capitalized terms used and not otherwise defined herein The term “Effective Date” shall have mean [●], 2021, the meanings set forth in that certain Exchange Agreement, dated April 5, 2020, between date the Company and the Holder Company’s Registration Statement on Form S‑1 (File No. 333-[●]) (the “AgreementRegistration Statement”) was declared effective by the Securities and Exchange Commission (the “Commission”) on [●], 2021 (and the offering covered thereby, the “Offering”).
Appears in 1 contract
Purchase Warrant. THIS CERTIFIES THAT, in consideration of funds duly paid by or on behalf of [INVESTOR] Brean Capital, LLC (“Holder”), as registered owner of this Purchase Warrant, to American BriVision (Holding) ClearSign Combustion Corporation., a Nevada company Washington corporation (the “Company”), Holder is entitled, at any time or from time to time from [●]March 5, 2020 2014 (the “Commencement Date”), and at or before 5:00 p.m., Eastern time, [●]March 5, 2023, 2019 (the “”Expiration Date”), but not thereafter, to subscribe for, purchase and receive, in whole or in part, up to [●] 20,313 shares of of common stock of the Company, par value $0.001 0.0001 per share (the “Shares”), subject to adjustment as provided in Section 5 6 hereof. If the Expiration Date is a day on which banking institutions are authorized by law to close, then this Purchase Warrant may be exercised on the next succeeding day which is not such a day in accordance with the terms herein. During the period ending on the Expiration Date, the Company agrees not to take any action that would terminate this the Purchase Warrant. This Purchase Warrant is initially exercisable at $5.00 10.00 per ShareShare (125% of the price of the Shares sold in the Offering); provided, however, that upon the occurrence of any of the events specified in Section 4 6 hereof, the rights granted by this Purchase Warrant, including the exercise price per Share and the number of Shares to be received upon such exercise, shall be adjusted as therein specified. The term “Exercise Price” shall mean the initial exercise price or the adjusted exercise price, depending on the context. Capitalized terms used and not otherwise defined herein shall have the meanings set forth in that certain Exchange Agreement, dated April 5, 2020, between the Company and the Holder (the “Agreement”).
Appears in 1 contract
Purchase Warrant. THIS CERTIFIES THAT, in consideration of funds duly paid by or on behalf of [INVESTOR] Platinum Arc LLC (“Holder”), as registered owner of this Purchase Warrant, to American BriVision (Holding) Corporation.Healthcare Triangle, Inc., a Nevada company Delaware corporation (the “Company”), Holder is entitled, at any time or from time to time from [●]April 11, 2020 2022 (the “Commencement Date”), and at or before 5:00 p.m., Eastern time, [●]October 12, 2023, 2026 (the “Expiration Date”), but not thereafter, to subscribe for, purchase and receive, in whole or in part, up to [●] 261,000 shares of of common stock of the Company, par value $0.001 0.00001 per share (the “Shares”), subject to adjustment as provided in Section 5 6 hereof. If the Expiration Date is a day on which banking institutions are authorized by law to close, then this Purchase Warrant may be exercised on the next succeeding day which is not such a day in accordance with the terms herein. During the period ending on the Expiration Date, the Company agrees not to take any action that would terminate this Purchase Warrant. This Purchase Warrant is initially exercisable at $5.00 4.40 per Share; provided, however, that upon the occurrence of any of the events specified in Section 4 6 hereof, the rights granted by this Purchase Warrant, including the exercise price per Share and the number of Shares to be received upon such exercise, shall be adjusted as therein specified. The term “Exercise Price” shall mean the initial exercise price or the adjusted exercise price, depending on the context. Capitalized terms used and not otherwise defined herein The term “Effective Date” shall have mean October 12, 2021, the meanings set forth in that certain Exchange Agreement, dated April 5, 2020, between date on which the Registration Statement on Form S-1 (File No. 333-259180) of the Company was declared effective by the Securities and the Holder Exchange Commission (the “AgreementRegistration Statement”).
Appears in 1 contract
Purchase Warrant. THIS CERTIFIES THAT, in consideration of funds duly paid by or on behalf of [INVESTOR] ThinkEquity LLC (“Holder”), as registered owner of this Purchase Warrant, to American BriVision (Holding) Corporation.BioVie Inc., a Nevada company corporation (the “Company”), Holder is entitled, at any time or from time to time from [●]August 11, 2020 2025 (the “Commencement Date”), and at or before 5:00 p.m., Eastern New York City time, [●]August 11, 2023, 2030 (the “Expiration Date”), but not thereafter, to subscribe for, purchase and receive, in whole or in part, up to [●] shares of of common stock of the Company, par value $0.001 0.0001 per share (the “Shares”), subject to adjustment as provided in Section 5 6 hereof. If the Expiration Date is a day on which banking institutions in the State of New York are authorized by law to close, then this Purchase Warrant may be exercised on the next succeeding day which is not such a day in accordance with the terms hereinhereof. During the period ending on the Expiration Date, the Company agrees not to take any action that would terminate this Purchase Warrant. This Purchase Warrant is initially exercisable at $5.00 2.50 per Share; provided, however, that upon the occurrence of any of the events specified in Section 4 6 hereof, the rights granted by this Purchase Warrant, including the exercise price per Share and the number of Shares to be received upon such exercise, shall be adjusted as therein specified. The term “Exercise Price” shall mean the initial exercise price or the adjusted exercise price, depending on the context. Capitalized terms used and not otherwise defined herein The term “Effective Date” shall have mean August 7, 2025, the meanings set forth in that certain Exchange Agreement, dated April 5, 2020, between date on which the Registration Statement on Form S-1 (File No. 333-288525) of the Company was declared effective by the Securities and the Holder Exchange Commission (the “AgreementCommission”).
Appears in 1 contract
Sources: Underwriting Agreement (Biovie Inc.)
Purchase Warrant. THIS CERTIFIES THAT, in consideration of funds duly paid by or on behalf of [INVESTOR] Spartan Capital Securities, LLC (“Holder”), as registered owner of this Purchase Warrant, to American BriVision (Holding) Corporation.Warrant of Elephant Oil Corp., a Nevada company corporation (the “Company”), Holder is entitled, at any time or from time to time from [●], 2020 ] (the “Commencement Date”), and at or before 5:00 p.m., Eastern time, [●], 2023, ] (the “Expiration Date”), but not thereafter, to subscribe for, purchase and receive, in whole or in part, up to [●] shares of of common stock of the Company, par value $0.001 0.0001 per share (the “Shares”), subject to adjustment as provided in Section 5 6 hereof. If the Expiration Date is a day on which banking institutions are authorized by law to close, then this Purchase Warrant may be exercised on the next succeeding day which is not such a day in accordance with the terms herein. During the period ending on the Expiration Date, the Company agrees not to take any action that would terminate this Purchase Warrant. This Purchase Warrant is initially exercisable at $5.00 [●] per Share; provided, however, that upon the occurrence of any of the events specified in Section 4 6 hereof, the rights granted by this Purchase Warrant, including the exercise price per Share and the number of Shares to be received upon such exercise, shall be adjusted as therein specified. The term “Exercise Price” shall mean the initial exercise price of 110% of the offering price or the adjusted exercise price, depending on the context. Capitalized terms used and not otherwise defined herein The term “Effective Date” shall have mean [●], the meanings set forth in that certain Exchange Agreement, dated April 5, 2020, between date on which the Registration Statement on Form S-1 (File No. 333-263879) of the Company was declared effective by the Securities and the Holder (the “Agreement”)Exchange Commission.
Appears in 1 contract
Sources: Representative’s Warrant Agreement (Elephant Oil Corp.)
Purchase Warrant. THIS CERTIFIES THAT, in consideration of funds duly paid by or on behalf of [INVESTOR] ThinkEquity LLC (“Holder”), as registered owner of this Purchase Warrant, to American BriVision (Holding) Corporation.BioVie Inc., a Nevada company corporation (the “Company”), Holder is entitled, at any time or from time to time from [●]August 11, 2020 2025 (the “Commencement Date”), and at or before 5:00 p.m., Eastern New York City time, [●]August 11, 2023, 2030 (the “Expiration Date”), but not thereafter, to subscribe for, purchase and receive, in whole or in part, up to [●] _________ shares of of common stock of the Company, par value $0.001 0.0001 per share (the “Shares”), subject to adjustment as provided in Section 5 6 hereof. If the Expiration Date is a day on which banking institutions in the State of New York are authorized by law to close, then this Purchase Warrant may be exercised on the next succeeding day which is not such a day in accordance with the terms hereinhereof. During the period ending on the Expiration Date, the Company agrees not to take any action that would terminate this Purchase Warrant. This Purchase Warrant is initially exercisable at $5.00 2.50 per Share; provided, however, that upon the occurrence of any of the events specified in Section 4 6 hereof, the rights granted by this Purchase Warrant, including the exercise price per Share and the number of Shares to be received upon such exercise, shall be adjusted as therein specified. The term “Exercise Price” shall mean the initial exercise price or the adjusted exercise price, depending on the context. Capitalized terms used and not otherwise defined herein The term “Effective Date” shall have mean August 7, 2025, the meanings set forth in that certain Exchange Agreement, dated April 5, 2020, between date on which the Registration Statement on Form S-1 (File No. 333-288525) of the Company was declared effective by the Securities and the Holder Exchange Commission (the “AgreementCommission”).
Appears in 1 contract
Purchase Warrant. THIS CERTIFIES THAT, in consideration of funds duly paid by or on behalf of [INVESTOR] E▇ ▇▇▇▇▇▇, division of Benchmark Investments, LLC (“Holder”), as registered owner of this Purchase Warrant, to American BriVision (Holding) Corporation.Healthcare Triangle, Inc., a Nevada company Delaware corporation (the “Company”), Holder is entitled, at any time or from time to time from [●]April 11, 2020 2022 (the “Commencement Date”), and at or before 5:00 p.m., Eastern time, [●]October 12, 2023, (the 2026(the “Expiration Date”), but not thereafter, to subscribe for, purchase and receive, in whole or in part, up to [●] 261,000 shares of of common stock of the Company, par value $0.001 0.00001 per share (the “Shares”), subject to adjustment as provided in Section 5 6 hereof. If the Expiration Date is a day on which banking institutions are authorized by law to close, then this Purchase Warrant may be exercised on the next succeeding day which is not such a day in accordance with the terms herein. During the period ending on the Expiration Date, the Company agrees not to take any action that would terminate this Purchase Warrant. This Purchase Warrant is initially exercisable at $5.00 per 4.40per Share; provided, however, that upon the occurrence of any of the events specified in Section 4 6 hereof, the rights granted by this Purchase Warrant, including the exercise price per Share and the number of Shares to be received upon such exercise, shall be adjusted as therein specified. The term “Exercise Price” shall mean the initial exercise price or the adjusted exercise price, depending on the context. Capitalized terms used and not otherwise defined herein The term “Effective Date” shall have mean October 12, 2021, the meanings set forth in that certain Exchange Agreement, dated April 5, 2020, between date on which the Registration Statement on Form S-1 (File No. 333-259180) of the Company was declared effective by the Securities and the Holder Exchange Commission (the “AgreementRegistration Statement”).
Appears in 1 contract
Purchase Warrant. THIS CERTIFIES THAT, in consideration of funds duly paid by or on behalf of [INVESTOR●] (“Holder”), as registered owner of this Purchase Warrant, to American BriVision (Holding) Corporation.Hempacco Co., Inc., a Nevada company corporation (the “Company”), Holder is entitled, at any time or from time to time from [●]beginning February 14, 2020 2023 (the “Commencement Issue Date”), and at or before 5:00 p.m., Eastern time, [●]February 10, 2023, 2028 (the “Expiration Date”), but not thereafter, to subscribe for, purchase and receive, in whole or in part, up to [●338,100] shares of of common stock of the Company, par value $0.001 per share (the “Shares”), subject to adjustment as provided in Section 5 6 hereof. If the Expiration Date is a day on which banking institutions are authorized by law to close, then this Purchase Warrant may be exercised on the next succeeding day which is not such a day in accordance with the terms herein. During the period ending on the Expiration Date, the Company agrees not to take any action that would terminate this Purchase Warrant. This Purchase Warrant is initially exercisable at $5.00 1.50 per Share; provided, however, that upon the occurrence of any of the events specified in Section 4 6 hereof, the rights granted by this Purchase Warrant, including the exercise price per Share and the number of Shares to be received upon such exercise, shall be adjusted as therein specified. The term “Exercise Price” shall mean the initial exercise price or the adjusted exercise price, depending on the context. Capitalized terms used and not otherwise defined herein shall have the meanings set forth in that certain Exchange Agreement, dated April 5, 2020, between the Company and the Holder (the “Agreement”).
Appears in 1 contract
Purchase Warrant. THIS CERTIFIES THAT, in consideration of funds duly paid by or on behalf of [INVESTOR_____] (“Holder”), as registered owner of this Purchase Warrant, to American BriVision (Holding) Corporation.Cannabics Pharmaceuticals Inc., a Nevada company corporation (the “Company”), Holder is entitled, at any time or from time to time from [●]March 26, 2020 2019 (the “Commencement Date”), and at or before 5:00 p.m., Eastern time, [●]March 26, 2023, 2022 (the “”Expiration Date”), but not thereafter, to subscribe for, purchase and receive, in whole or in part, up to [●____] shares of of common stock of the Company, par value $0.001 0.0001 per share (the “Shares”), subject to adjustment as provided in Section 5 6 hereof. If the Expiration Date is a day on which banking institutions are authorized by law to close, then this Purchase Warrant may be exercised on the next succeeding day which is not such a day in accordance with the terms herein. During the period ending on the Expiration Date, the Company agrees not to take any action that would terminate this Purchase Warrant. This Purchase Warrant is initially exercisable at $5.00 0.9375 per Share; provided, however, that upon the occurrence of any of the events specified in Section 4 6 hereof, the rights granted by this Purchase Warrant, including the exercise price per Share and the number of Shares to be received upon such exercise, shall be adjusted as therein specified. The term “Exercise Price” shall mean the initial exercise price or the adjusted exercise price, depending on the context. Capitalized terms used and not otherwise defined herein shall have the meanings set forth in that certain Exchange Agreement, dated April 5, 2020, between the Company and the Holder (the “Agreement”).
Appears in 1 contract
Sources: Purchase Warrant Agreement (Cannabics Pharmaceuticals Inc.)
Purchase Warrant. THIS CERTIFIES THAT, in consideration of funds duly paid by or on behalf of [INVESTOR·] (“Holder”), as registered owner of this Purchase Warrant, to American BriVision (Holding) Corporation.Manhattan Bridge Capital, Inc., a Nevada company New York corporation (the “Company”), Holder is entitled, at any time or from time to time from [●]August 9, 2020 2017 (the one-year anniversary of the effective date of the Offering, the “Commencement Date”), and at or before 5:00 p.m., Eastern time, [●]August 9, 20232021 (the five-year anniversary of the effective date of the Offering, (the “Expiration Date”), but not thereafter, to subscribe for, purchase and receive, in whole or in part, up to [●·] common shares of of common stock of the Company, par value $0.001 per share (the “Shares”), subject to adjustment as provided in Section 5 6 hereof. If the Expiration Date is a day on which banking institutions are authorized by law to close, then this Purchase Warrant may be exercised on the next succeeding day which is not such a day in accordance with the terms herein. During the period ending on the Expiration Date, the Company agrees not to take any action that would terminate this the Purchase Warrant. This Purchase Warrant is initially exercisable at $5.00 7.4375 per ShareShare (125% of the price of the Shares sold in the Offering); provided, however, that upon the occurrence of any of the events specified in Section 4 6 hereof, the rights granted by this Purchase Warrant, including the exercise price per Share and the number of Shares to be received upon such exercise, shall be adjusted as therein specified. The term “Exercise Price” shall mean the initial exercise price or the adjusted exercise price, depending on the context. Capitalized terms used and not otherwise defined herein shall have the meanings set forth in that certain Exchange Agreement, dated April 5, 2020, between the Company and the Holder (the “Agreement”).
Appears in 1 contract
Sources: Representative’s Warrant Agreement (Manhattan Bridge Capital, Inc)
Purchase Warrant. THIS CERTIFIES THAT, in consideration of funds duly paid by or on behalf of [INVESTOR] ThinkEquity LLC (“Holder”), as registered owner of this Purchase Warrant, to American BriVision (Holding) Corporation.BioVie Inc., a Nevada company corporation (the “Company”), Holder is entitled, at any time or from time to time from [●________________], 2020 1 (the “Commencement Date”), and at or before 5:00 p.m., Eastern New York City time, [●____________], 2023, 2 (the “Expiration Date”), but not thereafter, to subscribe for, purchase and receive, in whole or in part, up to [●] shares of of common stock of the Company, par value $0.001 0.0001 per share (the “Shares”), subject to adjustment as provided in Section 5 6 hereof. If the Expiration Date is a day on which banking institutions in the State of New York are authorized by law to close, then this Purchase Warrant may be exercised on the next succeeding day which is not such a day in accordance with the terms hereinhereof. During the period ending on the Expiration Date, the Company agrees not to take any action that would terminate this Purchase Warrant. This Purchase Warrant is initially exercisable at $5.00 [●]3 per Share; provided, however, that upon the occurrence of any of the events specified in Section 4 6 hereof, the rights granted by this Purchase Warrant, including the exercise price per Share and the number of Shares to be received upon such exercise, shall be adjusted as therein specified. The term “Exercise Price” shall mean the initial exercise price or the adjusted exercise price, depending on the context. Capitalized terms used and not otherwise defined herein The term “Effective Date” shall have mean [_______, 2025], the meanings set forth in that certain Exchange Agreement, dated April 5, 2020, between date on which the Registration Statement on Form S-1 (File No. 333-[*]) of the Company was declared effective by the Securities and the Holder Exchange Commission (the “AgreementCommission”).
Appears in 1 contract
Sources: Underwriting Agreement (Biovie Inc.)
Purchase Warrant. THIS CERTIFIES THAT, in consideration of funds duly paid services rendered by or on behalf of [INVESTOR] Aegis Capital Corp. (“Aegis”) to American DG Energy Inc., a Delaware corporation (the “Company”) in connection with the Offering (as hereinafter defined),_______________ (“Holder”), as registered owner of this Purchase Warrant, to American BriVision (Holding) Corporation., a Nevada company (the “Company”), Holder is entitled, at any time or from time to time from [●]July 31, 2020 2015 (the “Commencement Date”), and at or before 5:00 p.m., Eastern time, [●]July 31, 2023, 2019 (the “Expiration Date”), but not thereafter, to subscribe for, purchase and receive, in whole or in part, up to [●] 112,538 shares of of common stock of the Company, par value $0.001 per share (the “Shares”), subject to adjustment as provided in Section 5 6 hereof. If the Expiration Date is a day on which banking institutions are authorized by law to close, then this Purchase Warrant may be exercised on the next succeeding day which is not such a day in accordance with the terms herein. During the period ending on the Expiration Date, the Company agrees not to take any action that would terminate this Purchase Warrant. This Purchase Warrant is initially exercisable at $5.00 1.8875 per Share; provided, however, that upon the occurrence of any of the events specified in Section 4 6 hereof, the rights granted by this Purchase Warrant, including the exercise price per Share and the number of Shares to be received upon such exercise, shall be adjusted as therein specified. The term “Exercise Price” shall mean the initial exercise price or the adjusted exercise price, depending on the context. Capitalized terms used and not otherwise defined herein The term “Offering” shall have the meanings set forth meaning ascribed to that term in that certain Exchange Agreementthe Underwriting Agreement dated as of July 31, dated April 5, 2020, 2014 by and between the Company and the Holder Underwriters parties thereto (the “Underwriting Agreement”).
Appears in 1 contract
Purchase Warrant. THIS CERTIFIES THAT, in consideration of funds duly paid by or on behalf of [INVESTOR●] (“Holder”), as registered owner of this Purchase Warrant, to American BriVision (Holding) Corporation.Perfect Moment, Ltd., a Nevada company Delaware corporation (the “Company”), Holder is entitled, at any time or from time to time from [●]August 27, 2020 2025 (the “Commencement Date”), and at or before 5:00 p.m., Eastern time, [●]on August 27, 2023, 2028 (the “Expiration Date”), but not thereafter, to subscribe for, purchase and receive, in whole or in part, up to [●] 3,204,908 shares of of common stock of the Company, par value $0.001 0.0001 per share (the “Shares”), subject to adjustment as provided in Section 5 7 hereof. If the Expiration Date is a day on which banking institutions are authorized by law to close, then this Purchase Warrant may be exercised on the next succeeding day which is not such a day in accordance with the terms herein. During the period ending on the Expiration Date, the Company agrees not to take any action that would terminate this Purchase Warrant. This Purchase Warrant is initially exercisable at $5.00 0.46822 per Share; provided, however, that upon the occurrence of any of the events specified in Section 4 7 hereof, the rights granted by this Purchase Warrant, including the exercise price per Share and the number of Shares to be received upon such exercise, shall be adjusted as therein specified. The term “Exercise Price” shall mean the initial exercise price or as may be adjusted from time to time pursuant to the adjusted exercise price, depending on the contextterms hereof. Capitalized All capitalized terms used and but not otherwise defined herein shall have the meanings set forth ascribed to those in that certain Exchange Agreement, dated April 5, 2020, between the Company and the Holder Securities Purchase Agreement (the “Agreement”as defined below).
Appears in 1 contract
Purchase Warrant. THIS CERTIFIES THAT, in consideration of funds duly paid by or on behalf of [INVESTOR] Kingswood Capital Markets, division of Benchmark Investments, Inc. (“Holder”), as registered owner of this Purchase Warrant, to American BriVision (Holding) Corporation.Digital Brands Group, Inc., a Nevada company Delaware corporation (the “Company”), Holder is entitled, at any time or from time to time from [●]November 13, 2020 2021 (the “Commencement Date”), and at or before 5:00 p.m., Eastern time, [●]May 13, 2023, 2026 (the “Expiration Date”), but not thereafter, to subscribe for, purchase and receive, in whole or in part, up to [●] 120,482 shares of of common stock of the Company, par value $0.001 0.0001 per share (the “Shares”), subject to adjustment as provided in Section 5 6 hereof. If the Expiration Date is a day on which banking institutions are authorized by law to close, then this Purchase Warrant may be exercised on the next succeeding day which is not such a day in accordance with the terms herein. During the period ending on the Expiration Date, the Company agrees not to take any action that would terminate this Purchase Warrant. This Purchase Warrant is initially exercisable at $5.00 5.19 per ShareShare ; provided, however, that upon the occurrence of any of the events specified in Section 4 6 hereof, the rights granted by this Purchase Warrant, including the exercise price per Share and the number of Shares to be received upon such exercise, shall be adjusted as therein specified. The term “Exercise Price” shall mean the initial exercise price or the adjusted exercise price, depending on the context. Capitalized terms used and not otherwise defined herein The term “Effective Date” shall have mean May 13, 2021, the meanings set forth in that certain Exchange Agreement, dated April 5, 2020, between date on which the Registration Statement on Form S-1 (File No. 333- 255193) of the Company was declared effective by the Securities and the Holder (the “Agreement”)Exchange Commission.
Appears in 1 contract
Sources: Underwriting Agreement (Digital Brands Group, Inc.)
Purchase Warrant. THIS CERTIFIES THAT, in consideration of funds duly paid by or on behalf of [INVESTOR] ▇▇▇▇▇ ▇. ▇▇▇▇▇ (“Holder”), as registered owner of this Purchase WarrantWarrant of Stran & Company, to American BriVision (Holding) Corporation.Inc., a Nevada company corporation (the “Company”), Holder is entitled, at any time or from time to time from [●]May 12, 2020 2022 (the “Commencement Date”), and at or before 5:00 p.m., Eastern time, [●]November 12, 2023, 2026 (the “”Expiration Date”), but not thereafter, to subscribe for, purchase and receive, in whole or in part, up to [●] 62,287 shares of of common stock of the Company, par value $0.001 0.0001 per share (the “Shares”), subject to adjustment as provided in Section 5 6 hereof. If the Expiration Date is a day on which banking institutions are authorized by law to close, then this Purchase Warrant may be exercised on the next succeeding day which is not such a day in accordance with the terms herein. During the period ending on the Expiration Date, the Company agrees not to take any action that would terminate this Purchase Warrant. This Purchase Warrant is initially exercisable at $5.00 5.1875 per Share; provided, however, that upon the occurrence of any of the events specified in Section 4 6 hereof, the rights granted by this Purchase Warrant, including the exercise price per Share and the number of Shares to be received upon such exercise, shall be adjusted as therein specified. The term “Exercise Price” shall mean the initial exercise price or the adjusted exercise price, depending on the context. Capitalized terms used and not otherwise defined herein The term “Effective Date” shall have mean November 8, 2021, the meanings set forth in that certain Exchange Agreement, dated April 5, 2020, between date on which the Registration Statement on Form S-1 (File No. 333-260109) of the Company was declared effective by the Securities and the Holder (the “Agreement”)Exchange Commission.
Appears in 1 contract
Sources: Representative’s Warrant Agreement (Stran & Company, Inc.)
Purchase Warrant. THIS CERTIFIES THAT, in consideration of funds duly paid by or on behalf of [INVESTOR[ ] (“Holder”), as registered owner of this Purchase Warrant, to American BriVision (Holding) Corporation.Data443 Risk Mitigation, Inc., a Nevada company corporation (the “Company”), Holder is entitled, at any time or from time to time from [●beginning [ ], 2020 2023 (the “Commencement Date”), and at or before 5:00 p.m., Eastern time, [●[ ], 2023, 2028 (the “Expiration Date”), but not thereafter, to subscribe for, purchase and receive, in whole or in part, up to [●[ ] shares of of common stock of the Company, par value $0.001 per share (the “Shares”), subject to adjustment as provided in Section 5 6 hereof. If the Expiration Date is a day on which banking institutions are authorized by law to close, then this Purchase Warrant may be exercised on the next succeeding day which is not such a day in accordance with the terms herein. During the period ending on the Expiration Date, the Company agrees not to take any action that would terminate this Purchase Warrant. This Purchase Warrant is initially exercisable at $5.00 [ ] per Share; provided, however, that upon the occurrence of any of the events specified in Section 4 6 hereof, the rights granted by this Purchase Warrant, including the exercise price per Share and the number of Shares to be received upon such exercise, shall be adjusted as therein specified. The term “Exercise Price” shall mean the initial exercise price or the adjusted exercise price, depending on the context. Capitalized terms used and not otherwise defined herein shall have the meanings set forth in that certain Exchange Agreement, dated April 5, 2020, between the Company and the Holder (the “Agreement”).
Appears in 1 contract
Sources: Purchase Warrant Agreement (Data443 Risk Mitigation, Inc.)
Purchase Warrant. THIS CERTIFIES THAT, in consideration of funds duly paid by or on behalf of [INVESTOR] American Trust Investment Services, Inc. (“Holder”), as registered owner of this Purchase Warrant, to American BriVision (Holding) Corporation.Marwynn Holdings, Inc., a Nevada company corporation (the “Company”), Holder is entitled, at any time or from time to time from [●]September 11, 2020 2025 (the “Commencement Date”), and at or before 5:00 p.m., Eastern time, [●]March 11, 2023, 2030 (the “Expiration Date”), but not thereafter, to subscribe for, purchase and receive, in whole or in part, up to [●] shares of of common stock of the Company, par value $0.001 per share (the “Shares”), subject to adjustment as provided in Section 5 6 hereof. If the Expiration Date is a day on which banking institutions are authorized by law to close, then this Purchase Warrant may be exercised on the next succeeding day which is not such a day in accordance with the terms herein. During the period ending on the Expiration Date, the Company agrees not to take any action that would terminate this Purchase Warrant. This Purchase Warrant is initially exercisable at $5.00 4.80 per Share; provided, however, that upon the occurrence of any of the events specified in Section 4 6 hereof, the rights granted by this Purchase Warrant, including the exercise price per Share and the number of Shares to be received upon such exercise, shall be adjusted as therein specified. The term “Exercise Price” shall mean the initial exercise price or the adjusted exercise price, depending on the context. Capitalized terms used and not otherwise defined herein The term “Effective Date” shall have mean March 11, 2025, the meanings set forth in that certain Exchange Agreement, dated April 5, 2020, between date on which the Registration Statement on Form S-1 (File No. 333-284245) of the Company was declared effective by the Securities and the Holder (the “Agreement”)Exchange Commission.
Appears in 1 contract
Sources: Purchase Warrant Agreement (Marwynn Holdings, Inc.)
Purchase Warrant. THIS CERTIFIES THAT, in consideration of funds duly paid by or on behalf of [INVESTOR] Boustead Securities, LLC (“Holder”), as registered owner of this Purchase Warrant, to American BriVision (Holding) Corporation.Asset Entities Inc., a Nevada company corporation (the “Company”), Holder is entitled, at any time or from time to time from [●]beginning February 7, 2020 2023 (the “Commencement Date”), and at or before 5:00 p.m., Eastern time, [●]February 2, 2023, 2028 (the “Expiration Date”), but not thereafter, to subscribe for, purchase and receive, in whole or in part, up to [●] 105,000 shares (the “Shares”) of of common stock Class B Common Stock of the Company, par value $0.001 0.0001 per share (the “SharesCommon Stock”), subject to adjustment as provided in Section 5 6 hereof. If the Expiration Date is a day on which banking institutions are authorized by law to close, then this Purchase Warrant may be exercised on the next succeeding day which is not such a day in accordance with the terms herein. During the period ending on the Expiration Date, the Company agrees not to take any action that would terminate this Purchase Warrant. This Purchase Warrant is initially exercisable at $5.00 6.25 per Share; provided, however, that upon the occurrence of any of the events specified in Section 4 6 hereof, the rights granted by this Purchase Warrant, including the exercise price per Share and the number of Shares to be received upon such exercise, shall be adjusted as therein specified. The term “Exercise Price” shall mean the initial exercise price or the adjusted exercise price, depending on the context. Capitalized terms used and not otherwise defined herein shall have the meanings set forth in that certain Exchange Agreement, dated April 5, 2020, between the Company and the Holder (the “Agreement”).
Appears in 1 contract
Purchase Warrant. THIS CERTIFIES THAT, in consideration of funds duly paid by or on behalf of [INVESTOR] Feltl and Company, Inc. (“Holder”), as registered owner of this Purchase Warrant, to American BriVision (Holding) Corporation.The Joint Corp., a Nevada company Delaware corporation (the “Company”), Holder is entitled, at any time or from time to time from [●]November 10, 2020 2015 (the “Commencement Date”), and until at or before 5:00 p.m., Eastern time, [●]November 10, 2023, 2018 (the “Expiration Date”), but not thereafter, to subscribe for, purchase and receive, in whole or in part, up to [●] 67,500 shares of of common stock of the Company, par value $0.001 per share (the “Shares”), subject to adjustment as provided in Section 5 6 hereof. If the Expiration Date is a day on which banking institutions are authorized by law to close, then this Purchase Warrant may be exercised on the next succeeding day which is not such a day in accordance with the terms herein. During the period commencing on the Effective Date and ending on the Expiration Date, the Company agrees not to take any action that would terminate this Purchase Warrant. This Purchase Warrant is initially exercisable at $5.00 8.125 per Share; provided, however, that upon the occurrence of any of the events specified in Section 4 6 hereof, the rights granted by this Purchase Warrant, including the exercise price per Share and the number of Shares to be received upon such exercise, shall be adjusted as therein specified. The term “Exercise Price” shall mean the initial exercise price or the adjusted exercise price, depending on the context. Capitalized terms used and not otherwise defined herein The term “Effective Date” shall have mean November 10, 2014, the meanings set forth in that certain Exchange Agreement, dated April 5, 2020, between date on which the Registration Statement on Form S-1 (File No. 333-198860) of the Company was declared effective by the Securities and the Holder (the “Agreement”)Exchange Commission.
Appears in 1 contract
Sources: Purchase Warrant (JOINT Corp)
Purchase Warrant. THIS CERTIFIES THAT, in consideration of funds duly paid by or on behalf of [INVESTOR] ▇▇▇▇▇▇ ▇. ▇▇▇▇▇ (“Holder”), as registered owner of this Purchase WarrantWarrant of Stran & Company, to American BriVision (Holding) Corporation.Inc., a Nevada company corporation (the “Company”), Holder is entitled, at any time or from time to time from [●]May 12, 2020 2022 (the “Commencement Date”), and at or before 5:00 p.m., Eastern time, [●]November 12, 2023, 2026 (the “”Expiration Date”), but not thereafter, to subscribe for, purchase and receive, in whole or in part, up to [●] 62,287 shares of of common stock of the Company, par value $0.001 0.0001 per share (the “Shares”), subject to adjustment as provided in Section 5 6 hereof. If the Expiration Date is a day on which banking institutions are authorized by law to close, then this Purchase Warrant may be exercised on the next succeeding day which is not such a day in accordance with the terms herein. During the period ending on the Expiration Date, the Company agrees not to take any action that would terminate this Purchase Warrant. This Purchase Warrant is initially exercisable at $5.00 5.1875 per Share; provided, however, that upon the occurrence of any of the events specified in Section 4 6 hereof, the rights granted by this Purchase Warrant, including the exercise price per Share and the number of Shares to be received upon such exercise, shall be adjusted as therein specified. The term “Exercise Price” shall mean the initial exercise price or the adjusted exercise price, depending on the context. Capitalized terms used and not otherwise defined herein The term “Effective Date” shall have mean November 8, 2021, the meanings set forth in that certain Exchange Agreement, dated April 5, 2020, between date on which the Registration Statement on Form S-1 (File No. 333-260109) of the Company was declared effective by the Securities and the Holder (the “Agreement”)Exchange Commission.
Appears in 1 contract
Sources: Representative’s Warrant Agreement (Stran & Company, Inc.)
Purchase Warrant. THIS CERTIFIES THAT, in consideration of funds duly paid by or on behalf of [INVESTOR] Boustead Securities, LLC (“Holder”), as registered owner of this Purchase Warrant, to American BriVision (Holding) Corporation.Reticulate Micro, Inc., a Nevada company corporation (the “Company”), Holder is entitled, at any time or from time to time from beginning [●], 2020 2024 (the “Commencement Date”), and at or before 5:00 p.m., Eastern time, [●], 2023, 20292 (the “Expiration Date”), but not thereafter, to subscribe for, purchase and receive, in whole or in part, up to [●] shares (the “Shares”) of of class A common stock of the Company, par value $0.001 per share (the “SharesCommon Stock”), subject to adjustment as provided in Section 5 6 hereof. If the Expiration Date is a day on which banking institutions are authorized by law to close, then this Purchase Warrant may be exercised on the next succeeding day which is not such a day in accordance with the terms herein. During the period ending on the Expiration Date, the Company agrees not to take any action that would terminate this Purchase Warrant. This Purchase Warrant is initially exercisable at $5.00 [●]3 per Share; provided, however, that upon the occurrence of any of the events specified in Section 4 6 hereof, the rights granted by this Purchase Warrant, including the exercise price per Share and the number of Shares to be received upon such exercise, shall be adjusted as therein specified. The term “Exercise Price” shall mean the initial exercise price or the adjusted exercise price, depending on the context. Capitalized terms used and not otherwise defined herein shall have the meanings set forth in that certain Exchange Agreement, dated April 5, 2020, between the Company and the Holder (the “Agreement”).
Appears in 1 contract
Purchase Warrant. THIS CERTIFIES THAT, in consideration of funds duly paid by for value received, [•] or on behalf of [INVESTOR] its assigns (“Holder”), as registered owner of this Purchase Warrant, to American BriVision (Holding) Corporation., a Nevada company (the “Company”), Holder is entitled, at any time or from time to time from [●•], 2020 2016 (the “Commencement Date”), and until at or before 5:00 p.m., Eastern time, [●•], 2023, 2020 (the “Expiration Date”), but not thereafter, to subscribe for, purchase and receive, in whole or in part, up to [●•] shares of of common stock of Naked Brand Group, Inc., a Nevada corporation (the “Company”), par value $0.001 per share (the “Shares”), subject to adjustment as provided in Section 5 hereof. If the Expiration Date is a day on which banking institutions are authorized by law to close, then this Purchase Warrant may be exercised on the next succeeding day which is not such a day in accordance with the terms herein. During the period ending on the Expiration Date, the Company agrees not to take any action that would terminate this Purchase Warrant. This Purchase Warrant is initially exercisable at $5.00 4.80 per Share; provided, however, that upon the occurrence of any of the events specified in Section 4 5 hereof, the rights granted by this Purchase Warrant, including the exercise price per Share and the number of Shares to be received upon such exercise, shall be adjusted as therein specified. The term “Exercise Price” shall mean the initial exercise price or the adjusted exercise price, depending on the context. Capitalized terms used and not otherwise defined herein The term “Effective Date” shall have mean December 17, 2015, the meanings set forth in that certain Exchange Agreement, dated April 5, 2020, between date on which the Registration Statement on Form S-1 (File No. 333-207110) of the Company and the Holder (the “AgreementRegistration Statement”) was declared effective by the U.S. Securities and Exchange Commission (the “Commission”).
Appears in 1 contract
Purchase Warrant. THIS CERTIFIES THAT, in consideration of funds duly paid by or on behalf of [INVESTOR] Spartan Capital Securities, LLC (“Holder”), as registered owner of this Purchase Warrant, to American BriVision (Holding) Corporation.Warrant of Trio Petroleum Corp., a Nevada company Delaware corporation (the “Company”), Holder is entitled, at any time or from time to time from [●]April 20, 2020 2023 (the “Commencement Date”), and at or before 5:00 p.m., Eastern time, [●]April 17, 2023, 2028 (the “Expiration Date”), but not thereafter, to subscribe for, purchase and receive, in whole or in part, up to [●] 100,000 shares of of common stock of the Company, par value $0.001 0.0001 per share (the “Shares”), subject to adjustment as provided in Section 5 6 hereof. If the Expiration Date is a day on which banking institutions are authorized by law to close, then this Purchase Warrant may be exercised on the next succeeding day which is not such a day in accordance with the terms herein. During the period ending on the Expiration Date, the Company agrees not to take any action that would terminate this Purchase Warrant. This Purchase Warrant is initially exercisable at $5.00 3.30 per Share; provided, however, that upon the occurrence of any of the events specified in Section 4 6 hereof, the rights granted by this Purchase Warrant, including the exercise price per Share and the number of Shares to be received upon such exercise, shall be adjusted as therein specified. The term “Exercise Price” shall mean the initial exercise price or the adjusted exercise price, depending on the context. Capitalized terms used and not otherwise defined herein The term “Effective Date” shall have mean April 17, 2023, the meanings set forth in that certain Exchange Agreement, dated April 5, 2020, between date on which the Registration Statement on Form S-1 (File No. 333-267380) of the Company was declared effective by the Securities and the Holder (the “Agreement”)Exchange Commission.
Appears in 1 contract
Purchase Warrant. THIS CERTIFIES THAT, in consideration of funds duly paid by or on behalf of [INVESTOR] Aegis Capital Corp. (“Holder”), as registered owner holder of this warrant to purchase Class A ordinary shares (this “Purchase Warrant”), to American BriVision (Holding) Corporation.Youxin Technology Ltd, a Nevada Cayman Islands company (the “Company”), Holder is entitled, at any time or from time to time from [●], 2020 (beginning on the “Commencement Effective Date”), and at or before 5:00 p.m., Eastern time, [●]December 20, 2023, 2029 (the “Expiration Date”), but not thereafter, to subscribe for, purchase and receive, in whole or in part, up to [●] 115,000 Class A ordinary shares of of common stock (the “Shares”) of the Company, par value $0.001 0.0001 per share (the “Ordinary Shares”), subject to adjustment as provided in Section 5 6 hereof. If the Expiration Date is a day on which banking institutions are authorized by law to close, then this Purchase Warrant may be exercised on the next succeeding day which is not such a day in accordance with the terms herein. During the period ending on the Expiration Date, the Company agrees not to take any action that would terminate this Purchase Warrant. This Purchase Warrant is initially exercisable at $5.00 5.625 per Share; provided, however, that upon the occurrence of any of the events specified in Section 4 6 hereof, the rights granted by this Purchase Warrant, including the exercise price per Share and the number of Shares to be received upon such exercise, shall be adjusted as therein specified. The term “Exercise Price” shall mean the initial exercise price as set forth above or the adjusted exercise priceprice as a result of the events set forth in Section 6 hereof, depending on the context. Capitalized terms used and not otherwise defined herein shall have the meanings set forth in that certain Exchange Agreement, dated April 5, 2020, between the Company and the Holder (the “Agreement”).
Appears in 1 contract
Purchase Warrant. THIS CERTIFIES THAT, in consideration of funds duly paid by or on behalf of [INVESTOR] YA II PN, LTD. (“Holder” or “YA II”), as registered owner of this Purchase Warrant, to American BriVision (Holding) Corporation.Micronet Enertec Technologies, Inc., a Nevada company Delaware corporation (the “Company”), Holder is entitled, at any time or from time to time from [●]June 8, 2020 2017 (the “Commencement Date”), and at or before 5:00 p.m., Eastern time, [●]June 8, 2023, 2022 (the “Expiration Date”), but not thereafter, to subscribe for, purchase and receive, in whole or in part, up to [●] 90,000 shares of of common stock of the Company, par value $0.001 per share (the “Shares”), subject to adjustment as provided in Section 5 6 hereof. If the Expiration Date is a day on which banking institutions are authorized by law to close, then this Purchase Warrant may be exercised on the next succeeding day which is not such a day in accordance with the terms herein. During the period ending on the Expiration Date, the Company agrees not to take any action that would terminate this the Purchase Warrant. This Purchase Warrant is initially exercisable at $5.00 2.00 per Share; provided, however, that upon the occurrence of any of the events specified in Section 4 6 hereof, the rights granted by this Purchase Warrant, including the exercise price per Share and the number of Shares to be received upon such exercise, shall be adjusted as therein specified. The term “Exercise Price” shall mean the initial exercise price or the adjusted exercise price, depending on the context. Capitalized terms used and not otherwise defined herein shall have the meanings set forth in that certain Exchange Agreement, dated April 5, 2020, between the Company and the Holder (the “Agreement”).
Appears in 1 contract
Sources: Purchase Warrant Agreement (Micronet Enertec Technologies, Inc.)
Purchase Warrant. THIS CERTIFIES THAT, in consideration of funds duly paid by or on behalf of [INVESTOR] The Benchmark Company, LLC (“Holder”), as registered owner of this Purchase Warrant, to American BriVision (Holding) Corporation.Aqua Metals, Inc. a Nevada company Delaware corporation (the “Company”), Holder is entitled, at any time or from time to time from [●]beginning November 14, 2020 2024 (the “Commencement Date”), and at or before 5:00 p.m., Eastern time, [●]May 14, 2023, 2029 (the “Expiration Date”), but not thereafter, to subscribe for, purchase and receive, in whole or in part, up to [●] _____ shares of (the “Shares”) of common stock of the Company, par value $0.001 per share (the “SharesCommon Stock”), subject to adjustment as provided in Section 5 6 hereof. If the Expiration Date is a day on which banking institutions are authorized by law to close, then this Purchase Warrant may be exercised on the next succeeding day which is not such a day in accordance with the terms herein. During the period ending on the Expiration Date, the Company agrees not to take any action that would terminate this Purchase Warrant. This Purchase Warrant is initially exercisable at $5.00 _____2 per Share; provided, however, that upon the occurrence of any of the events specified in Section 4 6 hereof, the rights granted by this Purchase Warrant, including the exercise price per Share and the number of Shares to be received upon such exercise, shall be adjusted as therein specified. The term “Exercise Price” shall mean the initial exercise price or the adjusted exercise price, depending on the context. Capitalized terms used and not otherwise defined herein shall have 1 Number of shares to be 2% of the meanings set forth shares sold in that certain Exchange Agreement, dated April 5, 2020, between the Company offering and the Holder (number of shares for which the “Agreement”)warrants are initially exercisable, less shares/warrants sold to officers and directors. 2 125% if the public offering price of the shares sold in the offering.
Appears in 1 contract
Purchase Warrant. THIS CERTIFIES THAT, in consideration of funds duly paid by or on behalf of [INVESTOR] The Benchmark Company, LLC (“Holder”), as registered owner of this Purchase Warrant, to American BriVision (Holding) Corporation.TFF Pharmaceuticals, Inc. a Nevada company Delaware corporation (the “Company”), Holder is entitled, at any time or from time to time from [●]beginning February 14, 2020 2024 (the “Commencement Date”), and at or before 5:00 p.m., Eastern time, [●]August 17, 2023, 2028 (the “Expiration Date”), but not thereafter, to subscribe for, purchase and receive, in whole or in part, up to [●] 457,608 shares of (the “Shares”) of common stock of the Company, par value $0.001 per share (the “SharesCommon Stock”), subject to adjustment as provided in Section 5 6 hereof. If the Expiration Date is a day on which banking institutions are authorized by law to close, then this Purchase Warrant may be exercised on the next succeeding day which is not such a day in accordance with the terms herein. During the period ending on the Expiration Date, the Company agrees not to take any action that would terminate this Purchase Warrant. This Purchase Warrant is initially exercisable at $5.00 0.3125 per Share; provided, however, that upon the occurrence of any of the events specified in Section 4 6 hereof, the rights granted by this Purchase Warrant, including the exercise price per Share and the number of Shares to be received upon such exercise, shall be adjusted as therein specified. The term “Exercise Price” shall mean the initial exercise price or the adjusted exercise price, depending on the context. Capitalized terms used and not otherwise defined herein shall have the meanings set forth in that certain Exchange Agreement, dated April 5, 2020, between the Company and the Holder (the “Agreement”).
Appears in 1 contract
Sources: Purchase Warrant Agreement (TFF Pharmaceuticals, Inc.)
Purchase Warrant. THIS CERTIFIES THAT, in consideration of funds duly paid by or on behalf of [INVESTOR] ▇▇ ▇▇▇▇▇▇, division of Benchmark Investments, LLC (“▇▇ ▇▇▇▇▇▇”) to LQR House Inc., a Nevada corporation (the “Company”), ▇▇ ▇▇▇▇▇▇ Holdings LLC, being ▇▇ ▇▇▇▇▇▇’▇ designee, (“Holder”), as registered owner of this Purchase Warrant, to American BriVision (Holding) Corporation., a Nevada company (the “Company”), Holder is entitled, at any time or from time to time from [●]May 9, 2020 2024 (the “Commencement Date”), and at or before 5:00 p.m., Eastern time, [●]November 9, 2023, 2028 (the “Expiration Date”), but not thereafter, to subscribe for, purchase and receive, in whole or in part, up to [●] 7,857,143 shares of of common stock of the Company, par value $0.001 0.0001 per share (the “Shares”), subject to adjustment as provided in Section 5 6 hereof. If the Expiration Date is a day on which banking institutions are authorized by law to close, then this Purchase Warrant may be exercised on the next succeeding day which is not such a day in accordance with the terms herein. During the period ending on the Expiration Date, the Company agrees not to take any action that would terminate this Purchase Warrant. This Purchase Warrant is initially exercisable at $5.00 0.07 per Share; provided, however, that upon the occurrence of any of the events specified in Section 4 6 hereof, the rights granted by this Purchase Warrant, including the exercise price per Share and the number of Shares to be received upon such exercise, shall be adjusted as therein specified. The term “Exercise Price” shall mean the initial exercise price or the adjusted exercise price, depending on the context. Capitalized terms used and not otherwise defined herein The term “Effective Date” shall have mean November 9, 2023, the meanings set forth in that certain Exchange Agreement, dated April 5, 2020, between date on which the Registration Statement on Form S-1 (File No. 333-275363) of the Company was declared effective by the Securities and the Holder Exchange Commission (the “AgreementRegistration Statement”).
Appears in 1 contract
Purchase Warrant. THIS CERTIFIES THAT, in consideration of funds duly paid by or on behalf of [INVESTOR] Equity Trust Company Custodian, FBO: R▇▇▇▇▇▇▇ ▇▇▇▇▇ R▇▇▇▇ ▇▇▇ (“Holder”), as registered owner of this Purchase Warrant, to American BriVision (Holding) Corporation.Edison Nation, Inc., a Nevada company corporation (the “Company”), Holder is entitled, at any time or from time to time from [●], 2020 the date hereof (the “Commencement Date”), and at or before 5:00 p.m., Eastern time, [●]December 31, 2023, 2020 (the “Expiration Date”), but not thereafter, to subscribe for, purchase and receive, in whole or in part, up to [●] 125,000 shares of of common stock of the Company, par value $0.001 per share (the “Shares”), subject to adjustment as provided in Section 5 hereof. If the Expiration Date is a day on which banking institutions are authorized by law to close, then this Purchase Warrant may be exercised on the next succeeding day which is not such a day in accordance with the terms herein. During the period ending on the Expiration Date, the Company agrees not to take any action that would terminate this Purchase Warrant. This Purchase Warrant is initially exercisable at a fixed amount of $5.00 2.00 per Share; provided, however, that upon the occurrence of any of the events specified in Section 4 5 hereof, the rights granted by this Purchase Warrant, including the exercise price per Share and the number of Shares to be received upon such exercise, shall be adjusted as therein specified. The term “Exercise Price” shall mean the initial exercise price or the adjusted exercise price, depending on the context. Capitalized terms used and not otherwise defined herein shall have the meanings set forth in that certain Exchange Agreement, dated April 5, 2020, between the Company and the Holder (the “Agreement”).
Appears in 1 contract
Purchase Warrant. THIS CERTIFIES THAT, in consideration of funds duly paid by or on behalf of [INVESTOR] Benchmark Investments, LLC (“Holder”), as registered owner of this Purchase WarrantWarrant of Stran & Company, to American BriVision (Holding) Corporation.Inc., a Nevada company corporation (the “Company”), Holder is entitled, at any time or from time to time from [●]May 12, 2020 2022 (the “Commencement Date”), and at or before 5:00 p.m., Eastern time, [●]November 12, 2023, 2026 (the “”Expiration Date”), but not thereafter, to subscribe for, purchase and receive, in whole or in part, up to [●] 10,101 shares of of common stock of the Company, par value $0.001 0.0001 per share (the “Shares”), subject to adjustment as provided in Section 5 6 hereof. If the Expiration Date is a day on which banking institutions are authorized by law to close, then this Purchase Warrant may be exercised on the next succeeding day which is not such a day in accordance with the terms herein. During the period ending on the Expiration Date, the Company agrees not to take any action that would terminate this Purchase Warrant. This Purchase Warrant is initially exercisable at $5.00 5.1875 per Share; provided, however, that upon the occurrence of any of the events specified in Section 4 6 hereof, the rights granted by this Purchase Warrant, including the exercise price per Share and the number of Shares to be received upon such exercise, shall be adjusted as therein specified. The term “Exercise Price” shall mean the initial exercise price or the adjusted exercise price, depending on the context. Capitalized terms used and not otherwise defined herein The term “Effective Date” shall have mean November 8, 2021, the meanings set forth in that certain Exchange Agreement, dated April 5, 2020, between date on which the Registration Statement on Form S-1 (File No. 333-260109) of the Company was declared effective by the Securities and the Holder (the “Agreement”)Exchange Commission.
Appears in 1 contract
Sources: Representative’s Warrant Agreement (Stran & Company, Inc.)
Purchase Warrant. THIS CERTIFIES THAT, in consideration of funds duly paid by or on behalf of [INVESTOR] (“Holder”), as registered owner of this Purchase Warrant, to American BriVision (Holding) Corporation.Ceres, Inc., a Nevada company Delaware corporation (the “Company”), Holder is entitled, at any time or from time to time from [●]March 4, 2020 (the 2015(the “Commencement Date”), and at or before 5:00 p.m., Eastern time, [●]March 4, 2023, 2019 (the “”Expiration Date”), but not thereafter, to subscribe for, purchase and receive, in whole or in part, up to [●] 22,000 shares of of common stock of the Company, par value $0.001 0.01 per share (the “Shares”), subject to adjustment as provided in Section 5 hereof. If the Expiration Date is a day on which banking institutions are authorized by law to close, then this Purchase Warrant may be exercised on the next succeeding day which is not such a day in accordance with the terms herein. During the period ending on the Expiration Date, the Company agrees not to take any action that would terminate this Purchase Warrant. This Purchase Warrant is initially exercisable at $5.00 1.50 per Share; provided, however, that upon the occurrence of any of the events specified in Section 4 5 hereof, the rights granted by this Purchase Warrant, including the exercise price per Share and the number of Shares to be received upon such exercise, shall be adjusted as therein specified. The term “Exercise Price” shall mean the initial exercise price or the adjusted exercise price, depending on the context. Capitalized terms used and not otherwise defined herein shall have the meanings set forth in that certain Exchange Agreement, dated April 5, 2020, between the Company and the Holder (the “Agreement”).
Appears in 1 contract
Purchase Warrant. THIS CERTIFIES THAT, in consideration of funds duly paid by or on behalf of [INVESTOR] Boustead Securities, LLC (“Holder” or “Boustead”), as registered owner of this Purchase Warrant, to American BriVision (Holding) Corporation.China Xiangtai Food Co., Ltd, a Nevada Cayman Islands company (the “Company”), Holder is entitled, at any time or from time to time from [●]September 11, 2020 2018 (the “Commencement Date”), and at or before 5:00 p.m., Eastern time, [●]September 10, 2023, 2023 (the “Expiration Date”), but not thereafter, to subscribe for, purchase and receive, in whole or in part, up to [●] 4,667 ordinary shares of of common stock of the Company, par value $0.001 0.01 per share (the “Shares”), subject to adjustment as provided in Section 5 6 hereof. If the Expiration Date is a day on which banking institutions are authorized by law to close, then this Purchase Warrant may be exercised on the next succeeding day which is not such a day in accordance with the terms herein. During the period ending on the Expiration Date, the Company agrees not to take any action that would terminate this Purchase Warrant. This Purchase Warrant is initially exercisable at $5.00 3.00 per Share; provided, however, that upon the occurrence of any of the events specified in Section 4 6 hereof, the rights granted by this Purchase Warrant, including the exercise price per Share and the number of Shares to be received upon such exercise, shall be adjusted as therein specified. The term “Exercise Price” shall mean the initial exercise price or the adjusted exercise price, depending on the context. Capitalized terms used and not otherwise defined herein shall have This Purchase Warrant is being issued in connection with the meanings set forth in that certain Exchange Agreement, dated April 5, 2020, between private offering of the Company and the Holder prior to its proposed initial public offering (the “AgreementIPO”)) underwritten by Boustead Securities, LLC.
Appears in 1 contract
Sources: Purchase Warrant Agreement (China Xiangtai Food Co., Ltd.)
Purchase Warrant. THIS CERTIFIES THAT, in consideration of funds duly paid by or on behalf of [INVESTOR] Kingswood Capital Markets, division of Benchmark Investments, Inc. (“Holder”), as registered owner of this Purchase Warrant, to American BriVision (Holding) Corporation.Digital Brands Group, Inc., a Nevada company Delaware corporation (the “Company”), Holder is entitled, at any time or from time to time from [●]November 13, 2020 2021 (the “Commencement Date”), and at or before 5:00 p.m., Eastern time, [●]May 13, 2023, 2026 (the “”Expiration Date”), but not thereafter, to subscribe for, purchase and receive, in whole or in part, up to [●] 120,482 shares of of common stock of the Company, par value $0.001 0.0001 per share (the “Shares”), subject to adjustment as provided in Section 5 6 hereof. If the Expiration Date is a day on which banking institutions are authorized by law to close, then this Purchase Warrant may be exercised on the next succeeding day which is not such a day in accordance with the terms herein. During the period ending on the Expiration Date, the Company agrees not to take any action that would terminate this Purchase Warrant. This Purchase Warrant is initially exercisable at $5.00 5.19 per ShareShare ; provided, however, that upon the occurrence of any of the events specified in Section 4 6 hereof, the rights granted by this Purchase Warrant, including the exercise price per Share and the number of Shares to be received upon such exercise, shall be adjusted as therein specified. The term “Exercise Price” shall mean the initial exercise price or the adjusted exercise price, depending on the context. Capitalized terms used and not otherwise defined herein The term “Effective Date” shall have mean May 13, 2021, the meanings set forth in that certain Exchange Agreement, dated April 5, 2020, between date on which the Registration Statement on Form S-1 (File No. 333- 255193) of the Company was declared effective by the Securities and the Holder (the “Agreement”)Exchange Commission.
Appears in 1 contract
Sources: Representative’s Warrant Agreement (Digital Brands Group, Inc.)